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1 List of Abbreviations 
ABBREVIATIONS 
σB RNA polymerase subunit Sigma B 
2L4 WT three domain Mu50 Eap fragment, domains 2 to 4 
2L4D3 2L4, having a mutation in domain 3  
2L4D4 2L4, having a mutation in domain 4  
3L4 WT two domain Mu50 Eap fragment, domains 3 and 4 
3L4D3 3L4, having a mutation in domain 3  
3L4D4 3L4, having a mutation in domain 4 
aa  amino acid(s) 
agr accessory gene regulator 
AhpC alkylhydroxide reductase 
Arp 2/3  actin-related proteins 2/3 
BLAST basic local alignment search tool 
BSA  bovine serum albumin 
CatA Catalase A 
CFT-1 cells bronchial epithelial cells of a patient with cystic fibrosis 
cfu colony forming unit(s) 
CHIPS chemotaxis inhibitory protein of Staphylococcus aureus 
ClfA  clumping factor A 
ClfB  clumping factor B 
Cna  collagen adhesion protein 
Coa coagulase 
CR3 complement receptor 3 
CV column volume  
D3M domain 3 of the Mu50 Eap harboring a mutation  
D4M domain 4 of the Mu50 Eap harboring a mutation 
dsDNA double strand deoxyribonucleic acid 
DTT dithiothreitol 
DMSO dimethylsulfoxide 
Eap  extracellular adherence protein 
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ECL enhanced chemiluminescence 
ECM  extracellular matrix 
EDTA ethylenediaminetetraacetic acid  
EdU ethynyl-2- deoxyuridine 
Efb  extracellular fibrinogen-binding protein 
EGF epidermal growth factor  
EMBL European Molecular Biology Laboratory 
Emp  extracellular matrix binding protein 
Eno enolase 
EPEC enteropathogenic Escherichia coli 
Erk extracellular signal-regulated kinases 
EU endotoxin units 
FAME fatty acid-modifying enzyme 
FBS fetal bovine serum 
Fg fibrinogen 
FL full length  
FLD3 full length Mu50 Eap harboring a mutation in domain 3  
FLD4 full length Mu50 Eap harboring a mutation in domain 4 
FLIPr FPR-like 1 inhibitory protein 
Fn  fibronectin 
FnBPA fibronectin-binding protein A 
FnBPB fibronectin-binding protein B 
FPLC fast performance liquid chromatography  
GDP guanosine diphosphate 
GEF guanine nucleotide exchange factor 
GRB2 growth factor receptor-bound protein 2 
GTP guanosine-5'-triphosphate 
H2O2 hydrogen peroxide 
HaCat keratinocyte cell line 
HEK 293 Human Embryonic Kidney 293 cells 
HEPES  4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
ICAM-1 intercellular adhesion molecule-1 
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IgG  immunoglobulin G 
IgM immunoglobulin M 
IL-4  interleukin-4 
IPTG isopropyl-β-D-thiogalactopyranoside  
IU international unit 
KD dissociation constant  
KGF keratinocyte growth factor 
LAL limulus amebocyte lysate  
LB Luria Bertani medium 
LPS lipopolysaccharides  
LPXTG  Consensus motif found in bacterial proteins that are covalently attached to 
the bacterial cell-wall, sortase A recognition sequence 
MAP MHC analogues protein 
MAPK mitogen-activated protein kinases 
mAU milli-absorbance unit 
MEK MAPK/Erk kinase 
MHA Müller Hinton agar 
MHC major histocompatibility complex 
MOI multiplicity of infection 
MRSA Methicillin resistant Staphylococcus aureus 
MSCRAMM microbial surface components recognizing adhesive matrix molecules 
MSSA Methicillin sensitive Staphylococcus aureus 
NCBI National Center for Biotechnology Information 
Ni2+-NTA nickel nitrilotriacetic acid 
OD optical density 
PAGE polyacrylamide gel electrophoresis  
PBMC peripheral blood mononuclear cell 
PBS phosphate buffer saline 
PCR polymerase chain reaction  
PDGF platelet-derived growth factor  
Pkn protein-kinase 
PMSF phenylmethylsulphonylfluoride 
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psi pound-force per square inch 
RIPA  radioimmunoprecipitation assay  
RNA ribonucleic acids 
rpm revolutions per minute  
RTKs receptor tyrosine kinases 
sae S. aureus exoprotein expression 
Sak staphylokinase 
sar staphylococcal accessory regulator 
Sas proteins S. aureus surface proteins  
SCIN staphylococcal complement inhibitor 
SCVs small colony variants  
Sdr protein serin-aspartic acid rich proteins  
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SEB staphylococcal enterotoxin B 
SEC staphylococcal enterotoxin C 
SERAM secretable expanded repertoire adhesion molecule 
SH2 Src Homology 2 
SOS (son of sevenless) guanine nucleotide exchange factor 
Spa  Staphylococcus aureus protein A 
src rous sarcoma oncogene cellular homologue 
TAE tris-acetate-EDTA 
TB Terrific broth  
TBS T tris buffer saline containing 0.1% Tween-20 
TCR T-cell receptor 
TF tissue factor 
Th1/2 T helper cell 1/2 
TNF tissue necrosis factor 
TSST toxic shock syndrome  
UV ultraviolet visible 
VEGF vascular endothelial growth factor 
Vn  vitronectin 
WT wild type 
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Standard abbreviations for amino acids 
A  Ala  Alanine     
L  Leu  Leucine 
R  Arg Arginine     
K  Lys  Lysine 
N  Asn  Asparagine     
M  Met  Methionine 
D  Asp  Aspartic acid     
F  Phe  Phenylalanine 
C  Cys  Cysteine     
P  Pro  Proline 
Q  Gln  Glutamine     
S  Ser  Serine 
E  Glu  Glutamic acid    
T  Thr  Threonine 
G  Gly  Glycine     
V  Val  Valine 
H  His  Histidine     
W  Trp  Tryptophan 
I  Ile  Isoleucine     
Y  Tyr  Tyrosine 
 
Units 
 
Current strength Ampere A 
Concentration Molar 
Milimolar 
Micromolar 
M 
mM 
µM 
Length  Centimeter cm 
Mass Gram 
Microgram  
G 
µg 
Molecular weight Dalton  Da 
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Kilodalton  kDa 
Tension Volt V 
Temperature degree Celsius °C 
Volume Litre  
Millilitre  
Microlitre  
L  
ml 
µl 
Wave length  Nanometer nm 
Time  Second (s) 
Minute (s) 
Hour(s) 
s  
min 
 hr 
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2 Summary 
Staphylococcus aureus is a major human pathogen and a leading cause for both community and 
hospital acquired infections. The bacterium produces several virulence factors including the 
extracellular adherence protein (Eap), a member of the secreted expanded-repertoire adhesive 
molecules (SERAMs). With the majority of the secreted protein being bound back to the bacterial 
cell surface, Eap binds to a number of host cell matrix molecules, and posses some 
immunmodulatory and antiangiogenic properties. Depending on the genetic background of S. 
aureus, Eap consists of 3 to 6 repeats of the so-called Eap domain, a 110 amino acids spanning 
polypeptide sharing some homology to bacterial super-antigens. Although Eap is widely studied, 
only little is known about its structural and functional characteristics. The computational analysis 
of the Eap amino acid sequences performed in our laboratory identified a conserved YXNX motif 
in some of the Eap repeats, which might serve as putative tyrosine phosphorylation sites. To test 
whether and how the mutation of the tyrosine residue of this motif might affect the activities of 
this protein, we focused on the Eap of strain Mu50, which consists of four tandem repeats having 
YXNX motif in domains 1, 3 and 4. Eight different mutants were created by converting tyrosine 
to phenylalanine in the YXNX motifs of domains 3 and 4. This resulted in the construction of 
full-length Eap derivatives being mutated in domain 3 (FLD3) and  domain 4 (FLD4), two Eap 
domain fragments consisting of domains 2 to 4 and having a mutation in domain 3 (2L4D3) and  
4 (2L4D4), respectively, two Eap domain fragments consists of domains 3 and 4, having 
mutations in domain 3 (3L4D3), and 4 (3L4D4), respectively, and the single domain 3 (D3M) 
and 4 (D4M) mutants. All Eap derivatives were expressed in Escherichia coli strain BL21(DE3), 
and the proteins were purified by affinity- and size-exclusion chromatography. As adherence and 
internalization of bacteria into host cells are considered to be important steps during infection, we 
examined the role of the Eap derivatives on these two processes by the attachment and 
internalization of S. aureus strain SA113 into HaCaT cells that were preincubated with the Eap 
derivatives. We observed that the preincubation of HaCaT cells with the mutated full-length and 
2 domain Eap fragments (FLD3, FLD4, 3L4D3, and 3L4D4) clearly reduced the adherence and 
internalization of S. aureus into HaCaT cells if compared to the wild-type proteins (FL and 3L4), 
whereas all single domain Eap (both wild-type and mutant derivatives) showed no effect. In 
contrast, none of the mutations in the YXNX motifs of Eap domains 3 or 4 of the full-length Eap 
and the two domain Eap fragments (3L4D3 and 3L4D4) significantly altered the Eap effect on 
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either the keratinocyte growth factor stimulated ERK phosphorylation, or the proliferation of 
HaCaT cells, suggesting that the putative YXNX motifs of domains 3 and 4 exert an effect on 
some but not all activities of this protein. The molecular mechanism(s) by which the YXNX 
motifs affect the Eap activities still need to be identified.  
 
3 Zusammenfassung 
Staphylococcus aureus ist ein weitverbreitetes humanpathogenes Bakterium und ein wichtiger 
Verursacher von ambulant erworbenen und nosokomialen Infektionen. Der Erreger bildet eine 
Vielzahl von Virulenzfaktoren, zu denen auch das extrazelluläre Adhäsionsprotein Eap gehört. 
Dieses zu der Familie der SERAM (secreted expanded-repertoire adhesive molecules) gehörende 
Protein spielt eine wichtige Rolle bei der Infektion und Kolonialisierung der eukaryotischen 
Wirtszelle und verfügt neben seinen adhäsiven auch über immunmodulatorische Eigenschaften. 
Eap wurde bislang nur in S. aureus gefunden und ist in Abhängigkeit vom genetischen 
Hintergrund des jeweiligen Stammes aus 3 bis 6 Wiederholungen der sogenannten Eap-Domäne 
aufgebaut, eines 110 Aminosäuren umfassenden Polypeptids mit Ähnlichkeiten zu bakteriellen 
Superantigenen. Trotz zahlreicher Studien ist bislang wenig über den Zusammenhang zwischen 
Struktur und Funktion dieses Proteins bekannt. Bioinformatische Untersuchungen der 
verfügbaren Eap-Sequenzen in unserem Labor ergaben, dass einige Eap-Domänen ein 
konserviertes YXNX Motiv enthalten, bei dem es sich um eine mögliche Tyrosin-
Phosphorylierungsstelle handeln könnte. Die vorliegende Arbeit beschäftigt sich mit der Frage, 
ob Mutationen in diesem Motiv die Aktivität von Eap beeinflussen. Alle Untersuchungen wurden 
mit dem Eap des Stammes Mu50 durchgeführt, das aus vier Eap-Domänen besteht, von denen 
außer der zweiten alle Domänen ein YXNX Motiv enthalten. Um die Frage nach der Bedeutung 
der Tyrosine (Y), der mutmaßlichen Phosphorylierungsstellen in den YXNX Motiven des Mu50 
Eap zu beantworten, wurden acht Mutanten generiert, bei denen die Tyrosine in den YXNX 
Motiven der Domänen 3 und 4 durch Phenylalanine ersetzt wurden. Bei den Mutanten handelte 
es sich um zwei Volllängen- Eap Varianten, die je eine Mutation in Domäne 3 (FLD3) bzw. 
Domäne 4 (FLD4) tragen, sowie sechs verkürzte Eap Mutanten. Von den verkürzten Varianten 
bestehen zwei aus den Domänen 2 bis 4 und tragen je eine Mutation in Domäne 3 (2L4D3) bzw. 
Domäne 4 (2L4D4); zwei weitere umfassen nur die Domänen 3 und 4 und tragen ebenfalls je 
eine Mutation in Domäne 3 (3L4D3) bzw. Domäne 4 (3L4D4). Die letzten beiden Mutanten 
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bestehen nur aus einer einzigen, die Mutation tragenden Domäne (D3M und D4M). Alle Eap 
Varianten wurden heterolog in dem Escherichia coli Stamm BL21(DE3) exprimiert und über 
Affinitäts- und Größenausschluss-Chromatographie aufgereinigt. 
 
Da die Adhäsion eines Bakteriums an die Wirtszelle und seine anschließende Internalisierung 
wichtige Schritte bei der Entstehung einer Infektion darstellen, sollten die Eap-Mutanten auf ihre 
Funktionalität hinsichtlich dieser beiden Prozesse untersucht werden. Dazu wurde die Anhaftung 
bzw. Internalisierung des S. aureus Stamms SA113 an bzw. in HaCaT Zellen verfolgt, die mit 
den gereinigten Eap Mutanten präinkubiert wurden. Dabei zeigte sich, dass eine Präinkubation 
der HaCaT Zellen mit den beiden Volllängen-Eap Mutanten FLD3 und FLD4 sowie den 
verkürzten Eap Mutanten 3L4D3 und 3L4D4 jeweils zu einer deutlich reduzierten Adhäsion und 
Internalisierung der Bakterien im Vergleich zum jeweiligen Wildtyp (FL und 3L4) führte. Bei 
einer Präinkubation der Zellen mit den Eap Einzeldomänen D3 bzw D4 hingegen konnten weder 
bei den jeweiligen Wildtyp-Varianten noch bei den Mutanten (D3M bzw. D4M) Auswirkung auf 
Adhäsion und Internalisierung beobachtet werden. Darüber hinaus konnte gezeigt werden, dass 
sich Mutationen des YXNX Motivs der Eap Domänen 3 oder 4 weder auf die Aktiviät des Eap 
hinsichtlich des durch den Keratinozyten-Wachstumsfaktor stimulierten ERK Signalweges noch 
hinsichtlich der Proliferation der Wirtszellen auswirkten. Diese Befunde lassen darauf schliessen, 
dass Eap an den Tyrosinen der YXNX Motive phosphoryliert werden könnte und dies die 
Aktivität des Proteins beeinflusst, weisen zugleich aber auch darauf hin, dass diese mutmaßliche 
Phosphorylierung nicht für alle Aktivitäten des Eap gleichermaßen benötigt wird. Weiterführende 
Studien sind erforderlich, um den molekulare Mechanismus aufzuklären, durch den die YXNX 
Motive die Aktivität des Eap beeinflussen. 
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6 Introduction 
6.1 Staphylococcus aureus 
Staphylococcus aureus is a facultative anaerobic, gram-positive coccus. First described in 1880, 
the name Staphylococcus comes from the Greek word staphyle, meaning a bunch of grapes and 
reflecting its microscopic morphotype (Figure 1). On blood agar plates, it forms large, round, 
golden-yellow colonies, that are often surrounded by hemolytic areas. The carotenoid pigment 
staphyloxanthin is responsible for the characteristic golden colour in S. aureus, and is the 
etymological root of the bacteria's name; aureus, which means "golden" in Latin.  
 
 
 
Figure 1: Staphylococcus aureus under scanning electron microscope. (Adapted from 
www.healthhype.com/staphylococcus-aureus.html). 
S. aureus is a catalase-positive as it produces the enzyme "catalase", which converts hydrogen 
peroxide (H2O2) to water and oxygen. This particular enzymatic reaction is used to distinguish 
staphylococci from enterococci and streptococci. Within the staphylococci, S. aureus is usually 
differentiated from other staphylococcal species by the coagulase test. S. aureus produces the 
enzyme "coagulase" that causes clot formation, whereas most other Staphylococcus species, like 
S. epidermdis, S. saprohyticus, S. lugdunensis, S. schleiferi, and S. caprae, are coagulase-
negative.  
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S. aureus is a frequent commensal of humans. It is estimated that two thirds of the healthy 
population are transiently or permanently colonized by this organism, although pronounced 
variations depending on the geographic, ethnic, social and medical factors may exist. The 
bacterium is usually found in the nose and on the skin, but can be recovered from other moist 
regions of the body (e.g. the inguinal and perineal area, axilla, forehead, vagina and colon) as 
well. In the majority of cases, the bacterium does not cause disease, however, damages of the 
skin or other injuries may allow the bacterium to overcome natural protective mechanisms of the 
body, and may lead to infections. Although more than 30 staphylococcal species may lead to 
infections in humans, most infections are caused by S. aureus (Deurenberg et al., 2008). 
 
6.2 Pathogenesis and virulence factors 
S. aureus is a versatile and harmful pathogen of both hospital- and community acquired 
infections. It causes a variety of suppurative (pus-forming) infections and toxinosis in human. 
Pathogenicity of S. aureus is caused by the coordinate expression of a large arsenal of virulence 
factors, which can lead to superficial skin lesions such as pimples, impetigo, boils (furuncles), 
cellulitis folliculitis, carbuncles and abscesses up to life-threatening diseases such as pneumonia, 
meningitis, osteomyelitis, endocarditis, toxic shock syndrome (TSS), bacteremia, and sepsis 
(Fred, 2000). S. aureus may also cause food poisoning by releasing heat-stable enterotoxins into 
food products (Ortega et al., 2010).  
 
S. aureus produces a wide range of virulence factors, which are either surface associated or 
secreted. An important step in many types of infections is the bacterial adhesion to host tissues, 
which helps the bacteria to colonize and invade into host cells. The virulence factors of S. aureus 
have been comprehensively reviewed by T. Chavakis and colleagues (Chavakis et al., 2007), who 
categorized them into seven groups as illustrated in Figure 2. 
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Figure 2: Virulence determinants of Staphylococcus aureus. S. aureus expresses many 
potential virulence factors (Chavakis et al., 2007). (1) Microbial surface components 
recognizing adhesive matrix molecules (MSCRAMMs) including Fibronectin-binding protein 
A and B (FnBPs), clumping factors A and B, collagen-binding adhesin, serin-aspartic acidrich 
proteins (Sdr protein), S. aureus surface proteins (Sas proteins) and S. aureus protein A (Spa). (2) 
Secreted expanded repertoire adhesive molecules (SERAMs) including Eap (extracellular 
adherence protein), coagulase (Coa), extracellular matrix binding protein (Emp), extracellular 
fibrinogen-binding proteins (Efb) (3) Extracellular enzymes including catalases, alkylhydroxide 
reductase, thioredoxins and thioredoxin reductases, glycerol ester hydrolases, fatty acid-
modifying enzymes, various proteases (e.g. V8 protease, aureolysin, staphopain), O-
acetyltransferase, phosphatidylinositol -phospholipase C, staphylokinase and enolase.  (4) Toxins 
including α-toxin, β-hemolysin (also known as sphingomyelinase C), δ-hemolysin, bicomponent 
toxins: γ-hemolysin; Panton-Valentine leukocidin; leukocidins D, E, M, toxins with superantigen 
activity (staphylococcal enterotoxins, TSS), staphylococcal superantigen-like protein-5, 
staphylococcal superantigen-like protein-7, formylpeptides. (5) Anti inflammatory peptides 
including chemotaxis inhibitory proteins (CHIPS), FPR- like I inhibitory protein (FLIPr), 
staphylococcal complement inhibitor (SCIN). (6) Cell wall components including teichoic acid, 
wall component modifying factors, multiple peptide resistant factors. (7) Micro capsule 
including capsular polysaccharide. 
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6.2.1 Secreted expanded repertoire adhesive molecules (SERAMs).  
S. aureus produces a number of secreted bacterial proteins with extracellular matrix binding 
properties, the so-called SERAM. Although these secreted bacterial proteins are structurally 
unrelated, they share common functional features. SERAMs have the ability to bind to host 
factors and/or mediate bacterial adhesion to host molecules, cells, or tissues, and they do usually 
interfere with host defense mechanisms (Chavakis et al., 2005). The SERAM family also include 
the extracellular adherence protein (Eap), coagulase (Coa), the extracellular matrix binding 
protein (Emp) and the extracellular fibrinogen binding protein (Efb). 
 
6.2.1.1 S. aureus coagulase (Coa)  
The coagulase is a secretable 60-70 kDa protein containing a variable amino acid sequence 
comprising a prothrombin binding site, and a conserved region with multiple domain repeats. 
Prothrombin binding results in the formation of an active ‘staphthrombin’ complex, which 
converts fibrinogen to fibrin, and since decades, this reaction provides a hallmark for the 
microbiological diagnosis of S. aureus infections. Additionally, coagulase has been identified as 
a platelet-binding protein of S. aureus. In terms of pathogenesis, coagulase is thought to cause the 
production of a fibrin layer which contributes to the formation of a focal staphylococcal abscess, 
thus localizing the infection and protecting the organisms from phagocytosis. 
 
6.2.1.2 Extracellular matrix binding protein (Emp) 
The extracellular matrix binding protein (~40 kDa) has been shown to interact with fibronectin, 
fibrinogen, collagen, and vitronectin (Lee, 2001). Bacterial mutants deficient in Emp production 
were shown to attach with immobilized fibrinogen and fibronectin to a lower extent than the 
wild-type, and this difference could be complemented with the intact protein (Chavakis et al., 
2005).  
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6.2.1.3 Extracellular fibrinogen binding proteins (Efb) 
This small protein (15.6 kDa) was shown to bind to the α-chain of fibrinogen under in vitro 
conditions, however, it seems not to contribute to bacterial adherence to fibrinogen or fibrin in 
vivo . Instead, it binds and inhibits complement factor C3b and C3d, blocks opsono-phagocytosis, 
binds to platelets, and blocks the fibrinogen-induced platelet aggregation (Shannon et al., 2006). 
Efb is constitutively produced by all S. aureus strains investigated so far. Furthermore, in rat 
model Efb was shown to play a role in the pathogenesis of wound infections (Palma et al., 1996, 
1999). 
 
6.2.1.4 Extracellular adherence protein (Eap) 
The extracellular adherence protein (Eap) will be discussed in more detail in 6.4. 
 
6.3 Host pathogen interactions 
Since S. aureus is a primarily colonizing commensal of human, this bacterium must gain an 
entrance into its host to exert its pathogenic activity. Then it starts to establish an infection 
usually only under immune suppressive conditions and begins to express toxins and tissue 
degrading enzymes, which allow the pathogen to passage through tissue barriers. However, the 
high rates of relapse occurring after S. aureus infection, suggested that the bacterium may possess 
the ability to internalize and persist inside host cells. Likewise, S. aureus has been shown to 
internalize into a variety of non-professional phagocytic cell types, such as osteoblasts, 
fibroblasts, epithelail cells, and endothelial cells (Hagger et al., 2003). The binding of the 
bacterium to host cells and extracellular matrix (ECM) components is governed by cell wall-
anchored proteins, such as the Fn-binding proteins FnBPA and FnBPB, the clumping factors 
(ClfA, ClfB), and cell wall-associated factors such as Eap. Internalization of S. aureus into the 
eukaryotic cells, however, is thought to rely mainly on the fibronectin-mediated bridging between 
Fn-binding proteins FnBPA or FnBPB on the surface of staphylococci, and α5β1 integrin on host 
cell surface (Dziewanowska et al., 1999; Sinha et al., 1999). The invasion is thought to occur 
through a ′zipper type′ mechanism in which the bacteria bind directly or indirectly to the host cell 
receptors, which trigger the internalization of the receptors together with the bacteria. The 
bacteria are completely internalized in a time-, dose-, and temperature-dependent manner driven 
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by F-actin rearrangement in the host cell (Sinha et al., 1999), involving intracellular signaling 
such as tyrosine phosphorylation, MAPK activation (ERK-1 and ERK-2 phosphorylation), and 
Src kinase activation (Sinha et al., 2005). 
 
After invasion, endosome-localized S. aureus may escape into the cytoplasm (Bayles et al., 1998; 
Menzies and Kourteva, 1998; Sinha et al., 2005) or replicate inside the endosomes (Kahl et al., 
2000). The ability of S. aureus to persist within a host cell depends heavily on the control of 
exoprotein production by the bacterium. For example, S. aureus strain Cowan I, which weakly 
expresses exoproteins, survives within HEK 293 cells for days without damaging the host cells 
(Sinha et al., 1999), whereas S. aureus strain Newman, a high exotoxin producer, is highly 
cytotoxic and rapidly (within hours) destroys its host-cells. Consequently, the intracellular 
passage through endothelial cells seems to increase the formation of the so called “small colony 
variants” (SCVs), which are characterized by a reduced metabolism and virulence determinant 
production. These regulatory and metabolic adaptations may results into intracellular persistence 
of the bacteria and recurrent of disease (Vann et al., 1987). 
 
6.4 Eap (extracellular adherence protein) 
Eap is one of the most extensively studied SERAM of S. aureus, which was also designated as 
Map (MHC class II analogous protein) or P70. Youssif et al. (1991), described a highly cationic 
70 kDa (p70) protein from the cell surface of S. aureus strain Wood 46 that possessed a high 
affinity for the glomerular basement membrane of rats. Boden and Flock (1992) and McGavin et 
al., (1993) also reported about a 60-70 kDa staphylococcal surface protein in strains FDA574 and 
Newman, respectively which showed broad extracellular matrix binding properties by binding to 
fibrinogen, fibronectin and bone sialoprotein. Palma et al., (1999) finally characterized and 
named this protein as Eap, and confirmed its broad spectrum of binding activities to host cell 
components. Although the size of Eap varies considerably between strain to strain, the protein 
was found in more than 97% of all the clinical isolates of S. aureus (Hussian et al., 2001). 
Lacking the LPXTG motif found in MSCRAMMs, the secreted protein is linked to the bacterial 
cell surface by binding to the cell wall-associated neutral phosphatase (Nptase) (Palma et al., 
1999; Flock and Flock, 2001; Hussain et al., 2002). This property enables EAP to promote 
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adherence of S. aureus to host components as well as cells, including fibroblasts and epithelial 
cells  
 
Depending on the growth conditions, the expression of Eap in vitro appears to be maximal during 
the late exponential phase (Harraghy et al., 2005) or stationary phase (Joost et al., 2009), and the 
expression is tightly regulated by the sae two-component system (Harraghy et al., 2005). In 
addition, large differences have been observed for the production of Eap, with strain Newman 
producing considerably more Eap than all other strains tested to date (Hussain et al., 2001), due 
to a mutation in saeS, encoding the sensor-kinase of this two-component system (Adhikari et al., 
2008).  
6.4.1 Structural organization of Eap 
Eap was first characterized from strain FDA574, and was shown to consists of 689 amino acids 
including a signal peptide sequence (Jonsson et al., 1995), and a 110-amino acid domain that is 
repeated six times (Figure 3). Each domain includes a 31 amino acid sub-domain with great 
similarity to the N-terminus of β-chains of many major histocompatibility complex (MHC) class 
II molecules, which led to the name Map for MHC analogous protein. Sequencing of the eap 
gene of strain Newman identified an open reading frame which was in its N-terminal region 
homologous to the Map sequence characterized by Palma et al. (1999), but lacked the C-terminal 
domain found in the Map sequence of FDA574. Hussain et al., (2001) later on suggested that Eap 
and Map represent strain to strain variations of the same protein.  
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Figure 3: Structure of 72 kDa Map protein of S. aureus strain FDA 574. The protein consists 
of a signal sequence (S) of 30 amino acids followed by a unique sequence (U) of 19 amino acids 
of yet unknown function, and six repeated domains (1-6) of approximately 110 amino acids. 
Within each domain, there is a subdomain of 31 amino acids that is highly homologous to part of 
the peptide binding region in MHC class II molecule (modified after Jonsson et al., 1995). 
 
The crystal structure of the superantigen SEC bound to TCR β-chain was studied and suggests a 
presence of a potential ligand binding site within Eap (Fields et al., 1996). Moreover, the crystal 
structures of EAP domains were also solved and revealed a core fold that is comprised of an 
alpha-helix lying diagonally across a five stranded, mixed beta-sheet (Geisbrechts et al., 2005) 
which is depicted in Figure 4.  
 
Figure 4: The three-dimensional crystal structure of Eap2 (Mu50). The EAP domain 
structures consist primarily of a fourturn α-helix lying diagonally across one face of a 
fivestranded, mixed β-sheet and resemble an open hand holding a roll of coins (Geisbrecht et al, 
2005). 
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6.4.2 Properties of Eap 
6.4.2.1 Binding to plasma proteins 
Eap has a broad binding spectrum, and can bind to plasma proteins, eukaryotic cell receptors, and 
to itself. It is known to interact with at least seven plasma proteins such as vitronectin, 
fibronectin, fibrinogen, collagen, thrombospondin, prothrombin or osteopontin (McGavin et al., 
1993; Hussian et al., 2002, Hansen et al., 2006, Palma et al., 1999).  
 
6.4.2.2 Rebinding to the bacterial surface 
Since Eap is a secreted protein, it can rebind to the bacterial surface (Palma et al., 1999), 
however, the respective binding sites on the bacterial surface are not unequivocally identified. 
Externally added Eap was shown to rebind to S. aureus by the endogenous surface located Eap to 
create Eap-Eap interactions. However, this rebinding process was found to be independent from 
the endogenous Eap production (Hussain et al., 2002), as Eap-negative mutants were found to 
bind exogenous Eap like the wild-type strain, suggesting that there might be several Eap-binding 
structures on the cell surface that are capable of binding Eap. One of these targets is neutral 
phosphatase (Flock and Flock, 2001). Similarly, Kreikemeyer and colleagues identified two S. 
aureus cell surface proteins of 82 kDa and 50 kDa, respectively, which were capable of binding 
to Eap (Kreikemeyer et al., 2002). Moreover, Vuong et al., (2002)  showed that binding of Eap to 
the S. aureus cell wall was dependent on the D-alanylation of teichoic acids, as Eap was not 
bound to the surface of a S. aureus dlt (defective in the D-alanylation of teichoic acids) mutant,  
presumably due to altered electrostatic interactions. 
 
6.4.2.3 Agglutination of bacteria 
The capacity of Eap to multimerize also supports the bacterial aggregation, which is believed to 
contribute to the pathogenesis of this organism (Palma et al., 1999; Hagger et al., 2003). It was 
observed that externally added Eap enhanced the agglutination of S. aureus (Hussian et al., 
2002), and that the self-binding property of Eap contributed to this process (Hussian et al., 2008). 
 
 25 
6.4.2.4 Role of Eap in adherence and internalization 
Eap contributes to the adhesion of S. aureus to eukaryotic cells. Exogenously added Eap 
significantly enhanced the adherence of S. aureus to fibroblasts and epithelial cells, probably due 
to its dual affinity for plasma proteins on the cell surface and for the bacterium itself (Hussian et 
al., 2002). In addition, Eap also contributes to the internalization of S. aureus into eukaryotic 
cells (Hagger et al., 2003). 
 
6.4.2.5 Interaction with ICAM-1 
The endothelial cell adhesion molecule ICAM-1, which is also present on fibroblasts and 
epithelial cells, appears to be a major host "receptor" for Eap on eukaryotic cells. Eap was shown 
to inhibit the ICAM-1–integrin interactions and to block the ICAM-1-dependent leukocyte 
adhesion to the endothelium, resulting in the disruption of integrin-dependent leukocyte 
recruitment during in vitro and in vivo conditions, suggesting that Eap might serve as a potent 
anti-inflammatory factor (Athanasopoulos et al., 2006). In addition, Eap seems to affect the 
transendothalial migration, and the ICAM-1-mediated upregulation of NFκB activity as well as 
the expression of tissue factor (Athanasopoulos et al., 2006) 
 
Eap is also thought to have an important role in the pathogenesis of S. aureus by impairing 
wound healing, which is frequently seen in chronically S. aureus-infected wounds or ulcera 
(Madsen et al., 1996; Grimble et al., 2001). Eap was found to interfere with the recruitment of 
leukocytes into the infected tissue, and Eap-treated wounds were reported to show an impaired 
neovascularization. The protein was also shown to affect the formation of new blood vessels and 
capillary tube formation in vitro, indicating that Eap might inhibit cell proliferation (Sobke et al., 
2006).  
 
6.4.2.6 Role of Eap in immune response 
Beside its anti-inflammatory and antiangiogenetic properties, Eap seems to exert some 
immunomodulatory functions as well by interfering with T-cell functions by different means, 
thereby promoting immune tolerance to S. aureus and staphylococcal disease. Eap is capable of 
inducing a time and dose-dependent increase in IgM and IgG synthesis in PBMC (peripheral 
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blood mononuclear cell) cultures (Jahreis et al., 1995), and to induce an increased interleukin 
(IL)-4 synthesis in this cell type. In addition, Eap was reported to inhibit a delayed type 
hypersensitivity response and to induce T-cell death (Lee et al., 2002).  
 
6.5 Cell signaling 
The process of signaling within and between cells is critical for the living organism. The binding 
of most signaling molecule to its receptor initiates a series of intracellular reactions that regulate 
virtually all aspects of cell behavior including metabolism, movement, proliferation and 
differentiation. Investigations on the molecular mechanisms of these pathways has thus become a 
major area for research, especially with respect to host-pathogen interactions, as many pathogens 
utilize and exert their effects via these regulatory systems.  
 
6.5.1 The mitogen activated protein kinase pathway  
A wide variety of cellular stimuli, including growth factors, cytokines and extracellular matrix 
components, transmit signals to the nucleus via pathways involving tyrosine phosphorylation 
(Neel and Tonks, 1997; Pawson, 1995). The mitogen-activated protein kinase/extracellular 
regulated kinase (MAPK/ERK) cascade is a major signaling system by which the cell transduces 
extracellular signals into intracellular responses. The MAPK pathway (Figure 5) leads to a wide 
range of cellular responses, including cellular growth, differentiation, survival, inflammation and 
apoptosis. It is activated in response to many mitogenic stimuli, such as epidermal growth factors 
(EGF) and platelet derived growth factors (PDGF). The activation of these cascades classically 
involves ligand binding to receptor tyrosine kinases (RTKs) (1). Binding of growth factors to 
RTKs stimulates the autophosphorylation of specific tyrosines on the receptor. The 
phosphorylated receptor then interacts with an adaptor protein such as GRB2, which in turn, 
recuits SOS (son of sevenless) to the plasma membrane (2). SOS is a guanine nucleotide 
exchange factor which displaces GDP from Ras (GTPase), subsequently allowing the binding of 
GTP (3). GTP-bound Ras associates with the serine/threonine kinase Raf-1 (4), which is then 
activated by phosphorylation. Raf phosphorylates and activates the downstream kinase by 
phophorylating MEK (5). Phosphorylated MEK in turn phosphorylates ERK (6). Phosphorylated 
ERK moves from the cytoplasm into the nucleus where it subsequently phosphorylates a number 
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of transcription factors, including Elk-1 (7). Phosphorylated transcription factors turn on 
transcription (gene expression) of specific sets of target genes leading to the cell proliferation. 
The activity of Ras is limited by the hydrolysis of GTP back to GDP by GTPase activating 
proteins (GAP) (Figure 6). 
 
 
Figure 5: The mitogen-activated protein kinase pathway. (1) Cell membrane has receptor 
tyrosine kinases (RTKs). (2) Binding of growth factor to receptor activates the tyrosine kinase 
activity of the cytoplasmic domain of the receptor and phosphorylated on tyrosine residues. 
GRB2 binds to the guanine nucleotide exchange factor SOS (3) GRB2 SOS complex promotes 
the removal of GDP from a member of the Ras which then bind GTP and become active. (4) 
Activated Ras activates RAF (5) RAF kinase phosphorylates and activates MEK (6) MEK 
phosphorylates and activates an "extracellular signal-regulated kinases" (ERK) (7) ERKs are 
known to activate many transcription factors, such as ELK1. (Adopted from Vandebroek and 
Schrijvers (2007), with slight modifications). 
 
6.5.2 Ras signaling pathway 
Ras is a G protein with a molecular weight of 20-40 kDa. Like other G proteins, Ras can switch 
between GTP-bound and GDP-bound states (Figure 6) (Malumbres and Barbacid, 2002). 
Transition from the GDP-bound to the GTP-bound state is catalyzed by the guanine nucleotide 
exchange factor (GEF), which induces the exchange between the bound GDP and the cellular 
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GTP. The reverse transition is catalyzed by a GTPase-activating protein (GAP), which induces 
hydrolysis of the bound GTP. Ras or more specially, Ras/raf, is a key inducer which exerts a 
plethora of effects like apoptosis, translation, transcription, cell cycle progression, golgi 
trafficking vesicle formation, cell-cell junctions- and cytoskeletons modifications. Eap inhibits 
the activation of Ras by interfering with the Ras/Raf/MEK/ERK pathway (Sobke et al., 2006). 
 
 
Figure 6: Cycling of the Ras protein between active and inactive states. Ras signaling 
pathway. (a) Inactive form of Ras. (b) Removal of GDP by guanine nucleotide exchange factor 
(GEF) and adition of GTP. (c) Active form of Ras (d) GTPase-activating protein (GAP) which 
induces hydrolysis of the bound GTP into inactive form (Yarwood et al., 2006). 
 
6.6 Protein phosphorylation in bacteria 
Like in eukaryotes, phosphorylation of proteins is an important regulatory mechanism in bacteria. 
However, it was believed that eukaryotes use the Ser/Thr/Tyr phosphorylation for signal 
transduction, while bacteria use the Asp/His phosphorylation systems. The first serious crack in 
this picture came out with the characterization of the first serine/threonine eukaryotic-like 
protein-kinase (Pkn1) in the cyanobacterium Anabaena PCC 7120 (Zhang, 1993) and 
Myxococcus xanthus (Hanlon et al., 1997). Today, the widespread presence of eukayotic-like 
Ser/Thre kinase- and phosphatase-genes in bacteria is indisputable. Concerning the existence of 
bacterial proteins being phosphorylated at tyrosine residues, the first indication was reported in 
1982 for Escherichia coli (Wang et al., 1982). 
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A diverse strategies have been developed by pathogenic bacteria to interact with host cells to 
manipulate their behaviors, and thus to survive and propagate within its host. During the process 
of pathogenesis, phosphorylation of proteins at serine, threonine and tyrosine residues occurs at 
different stages including cell-cell interactions and adherence, translocation of bacterial effectors 
into host cells, and changes in the host cellular structure and function. The role of protein 
phosphorylation on serine/threonine/tyrosine residues and its effect on regulation of a variety of 
cellular functions has been the subject of intensive investigations (Hanlon et al., 1997; Motley et 
al., 1999; Peirs et al., 1997; Verma and Maurelli, 2003; Grangeasse et al., 2007; Ravichandran et 
al., 2009; Teqtmeyer et al, 2011), and is thought to play a great role in the process of 
pathogenesis (Cozzone, 2005). During the initiation of an infection, the bacterial pathogen has 
first to attach to the host cell. This is followed by pathogen invasion, survival and replication 
inside the host cell, which may end in cell intoxication and death of the eukaryotic cell. Although 
the mechanism to protect itself from host cell defense varies from species to species, certain 
common tactics are apparent that affect changes in gene expression, signal transduction 
pathways, cytoskeleton organization and vacuolar trafficking. During the invasion process, 
protein phosphorylation occurs at different stages, either within the bacterial pathogen or at/in the 
host cell. Several bacterial pathogens, such as enteropathogenic Escherichia coli (EPEC), 
Helicobacter pylori, Chlamydia trachomatis, Anaplasma phagocytophilum and Bartonella 
henselae, use secretion systems to inject tyrosine kinase substrates into host cells (Kenny et al., 
1997; Schulein et al., 2005; Segal et al., 1999) (Figure 7). After translocation, these proteins are 
usually phosphorylated on tyrosine residues by host cell kinases. Once phosphorylated, they react 
with other cytosolic proteins to modulate host cell functions for the benefit of the pathogen 
(Backert and Selbach, 2005).  
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Figure 7: Interaction partners of tyrosine phosphorylated bacterial proteins. (1) Bacterial 
pathogens inject proteins into mammalian cells. (2) Proteins are phosphorylated on tyrosine 
residues by a host cell kinase. (3) Phosphorylated proteins interact with other cytosolic proteins 
and interefere with host cell function (modified after Selbach et al., 2009). 
 
6.7 Selection of YXNX motif of Eap 
In bacteria, protein phosphorylation on tyrosine residues has been reported to involve in the 
control of heatshock response (Klein et al., 2003), adaptation to cold (Ray et al., 1994), 
adaptation to light (Warner and Bullerjahn, 1994), flagellin export (South et al., 1994), cell 
aggregation and sporulation (Frasch and Dworkin, 1996), and cell division and differentiation 
(Wu et al., 1999). However, there are only a few reports about bacterial effector proteins being 
tyrosine phosphorylated by eukaryotic kinases, and these bacterial proteins vary widely in their 
functions. Well studied tyrosine phosphorylated bacterial proteins include: The translocated 
intimin receptor Tir of the enteropathogenic E. coli (EPEC), which is required for 
attaching/effacing (A/E) lesion formation, induced change in the cytosol of infected host cell and 
induced nuclear signaling events (Kenny et al., 1997; DeVinney et al., 2001; Savkovic et al., 
1997);  the cytotoxin associated antigen A CagA of Helicobacter pylori, which modulates 
cellular signaling cascades of host cells (Puls et al., 2002; Segal et al., 1999); the translocated 
actin recruiting phosphoprotein Tarp of Chlamydia trachomatis, which helps in the actin-driven 
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uptake of bacteria by host epithelial cells (Clifton et al., 2004); the Bartonella exported protein D 
(BepD) of Bartonella henselae, which promotes cellular invasions and interfere signaling 
processes (Schulein et al., 2005); and the AnkA homolog of Anaplasma phagocytophilum, a 190 
kDa immunoreactive protein with ankyrin-like repeats that interact with host chromatin and 
nuclear components to downregulate key host defence genes (Ijdo et al., 2007).  
 
Because of the limited studies performed on the conserved region of the putative docking site for 
tyrosine phosphorylation, clear conclusions for the selection of such sites at the molecular-level 
are difficult to establish. However, in the nematode Caenorhabditis elegans it was found that 
SOC-2 and SHOC-2 proteins, which are rich in leucine repeats, contains two YXNX motifs, 
which are shown as a potential tyrosine-phosphorylated docking sites for the Src homology 2 
domain of SEM-5/GRB2 (Selfors et al., 1998). However, tyrosine phophorylation is not required 
for SOC-2 functions in vivo and tyrosine phosphorylation was not observed in SHOC-2 in 
response to FGF stimulations (Selfors et al., 1998). Moreover, it was also shown that the 
phosphorylation of Tyr-1009 of the platelet derived growth factor receptor (PDGFR) is involved 
in binding to GRB2, the adaptor protein composed out of two Src homology 3 (SH3) domains 
and one Src homology 2 (SH2) domain, which plays a critical role in the regulation of Ras 
(Lowenstein et al., 1992; Buday et al., 1994). The amount of the PDGFR bound to the GRB2 
beads was found to be significantly reduced by the tyrosine mutant Y1009F. Furthermore, during 
cell signaling it was also shown that GRB2 binds to Tyr-1068 (YINQ) in the EGF receptor and to 
the insulin receptor substrate 1 (IRS-1), where the conserved-domain of YXNX at Y-727, Y-895, 
and Y-939 (Barbacid et al., 1987; Skolnik et al., 1993; Smith et al., 1986) was available. In 
addition, it was also shown that GRB2 also binds to Shc (Rozakis-Adcock et al., 1992; Skolnik et 
al., 1993), apparently through a phosphorylated YVNV motif.  
 
A recent study by Sylvain Kerdudou at the Institute of Medical Microbiology and Hygiene, 
University of Saarland Hospitals, identified putative YXNX motifs in domains 1, 3 and 4 of the 
Mu50 Eap; with the YXNX motifs of domain 3 and 4 being highly conserved among all Eap 
amino acid sequences being available to date (unpublished PhD thesis). Interestingly, in this yet 
unpublished PhD work, S. Kerdudou showed in BiaCore studies that the domains 3 and 4 of the 
Mu50 Eap exhibited a higher interaction with β-arrestin (one of the alternative molecule of the 
heterotrimeric G proteins used by the seven transmembrane receptor family involved in the 
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transmission of extracellular signals across the plasma membrane to the cytosol) and NFAT-5 (a 
nuclear factor of activated T-cells, which is currently the only known mammalian transcription 
factor that regulates gene expression in response to extracellular hypertonicity, allowing the 
optimal cell proliferation under isotonic conditions). Furthermore, Eap fragments having domain 
4 possessed anti-angiogenic activities, while this was not the case with Eap fragments lacking 
this domain (Preissner and Herrmann, unpublished results). Therefore, we speculated that the 
conserved YXNX motifs of these domains might serve as potential phosporylation sites, which 
may modulate the activity of this protein. This hypothetical background was the starting point for 
this work. 
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7 Objectives 
7.1 General objective 
To construct mutants, lacking the tyrosine residues at the conserved YXNX motifs of the 
Mu50 Eap domains 3 and 4, and study the impact of the mutations on cellular processes 
known to be affected by Eap. 
 
7.2 Specific objectives 
1. To perform site directed mutagenesis at the conserved YXNX motifs of the full-length 
Eap protein (FLWT), three-domain (2L4WT), two-domain (3L4WT), and the single-
domain domain (D3WT) and (D4WT) of Mu50 Eap. 
2. To express and purify the wild-type and mutated Mu50 Eap fragments. 
3. To study the effect of the wild-type and mutated Mu50 Eap variants on adherence and 
internalization of bacteria into HaCaT cells. 
4. To study the effect of the Mu50 Eap wild-type and mutant proteins on ERK signaling and 
proliferation of HaCaT cells 
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8 Materials and Methods 
8.1 Materials 
The instruments, chemicals, enzymes, kits, reagents and other accessories used in this work were 
illustrated in Appendix II. 
 
8.1.1 Bacterial strains 
The Escherichia coli laboratory strain DH5α (Stratagene) was used for the transformation and 
plasmid amplification. The heterologous expression of the recombinant Mu50 Eap and the 
different variants of the mutated Eap were performed in E. coli BL21 (DE3) (Novagen). S. 
aureus strain SA113 (provided by A. Peschel, Tübingen) was used for the adherence and 
internalization assays.  
 
8.1.2 Vectors 
In this work, a set of pT7HMT expression vectors (Geisbrecht et al., 2006) having the insert of 
Mu50 eap open reading frame (full-length FL) and different eap fragment(s) were provided by 
Dr. B. V. Geisbrecht, (Division of cell biology and biophysics, school of biological science, 
University of Missouri-Kansas City, USA). The Mu50 Eap FL and different Eap fragments used 
in this study are shown in Table 1. The details of the vectors are illustrated in Appendix I. 1. 
 35 
Table 1: Staphylococcus aureus Mu50 Eap domains. The schematic representation and the 
length of the domains used in this work are shown. 
 
Mu50 Eap 
Wild type 
 
 
Abbrevation  
 
Diagrammatic representation 
Remark 
Length of 
amino acid 
Full-length  FLWT 
 
476  
 
Three domain having 
domain 2, 3 and 4 
 
2L4WT 
    
            
 
367  
 
Two domain having 
domain 3 and 4 
 
3L4WT 
 
 
 
263  
 
Single domain 1 D1WT 
 
MAP1*, 109  
 
Single domain 2 D2WT 
           
MAP2*, 110  
 
Single domain 3 D3WT 
                     
MAP3*, 109  
 
Single domain 4 D4WT 
 
                                 
MAP4*, 104  
 
Note: MAP* - MHC Analog Protein. The length of Eap repeats and the length of the amino acids 
are retrieved from www.uniprot.org/uniprot/Q99QS1.html. The Eap repeats of position 45-153, 
154-263, 264-372 and 373-476 amino acids are described as MAP1, MAP2, MAP3 and MAP4, 
respectively (Kuroda et al., 2001). 
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8.1.3 Oligonucleotides 
The oligonucleotides used to amplify the Mu50 eap and to construct the different eap mutants 
were purchased from MWG Biotechnology, Germany. The list of the primers that were used for 
the study is described in Table 2.  
 
Table 2: List of mutagenic and sequencing primers for the point mutation of YXNX motifs 
of Staphylococcus aureus Mu50 Eap. Nucleotides leading to a point mutation in the Mu50 Eap 
are shown in red.  
Description Forward Reverse Sequence (5´→3´)  
Primers for amplification of Eap domain 1 
RRY-5   
 
X  
AAAGTTAAATCAGTTTTATTCTTT
AATAGAGGTATTAG 
RRY-6  
 
 X CTAATACCTCTATTAAAGAATAAA
ACTGATTTAACTTT 
Primers for amplification of Eap domain 3 
RRY-3  
 
X  
CAAATAAACCTTGGACAAATTTCA
AAAATTTAACTAGTC 
RRY-4  
 
 X GACTAGTTAAATTTTTGAAATTTG
TCCAAGGTTTATTTG 
Primers for amplification of Eap domain 4 
RRY-1 
 
X  
CAATTAATTAGTTACAAATTTTTA
AACGACAAAGTG 
RRY-2  
 
 X 
CACTTTGTCGTTTAAAAATTTGTA
ACTAATTAATTG 
Primers for sequencing 
Description For Rev Sequence (5´→3´) 
T7 prom X  T TAATACGACTCACTATAGGG 
T7 term  X GCTAGTTATTGCTCAGCGG 
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8.2 Methods 
8.2.1 Sequence analysis 
The Eap amino acid sequences of 14 different strains of S. aureus [Mu50 (SAV1938), RF122 
(SAB1873c), N315 (SA1751), JH9 (A5IUA7), CI-7 (AJ243790), USA300 (ABX29943), 
MSSA476 (SAS1861), MW2 (EFK80959.1) , 8325 (ABD31208), COL (AAW36971), FDA547 
(Q53599), Newman mapN (AJ132841), MRSA252 (SAR2030) and Wood46 map-W 
(AJ245439)] were retrieved from the EMBL homepage and aligned using the CLUSTAL W 
program (www.ebi.ac.uk/clustalw).  
 
8.2.2 Preparation of competent cells 
Competency of bacterial cells for uptake of foreign DNA can be achieved by chemical or electro-
physical manipulations of cells. In this work, both types of cells were used. 
 
8.2.2.1 Preparation of chemically competent cells 
Chemically competent cells were used for protein expression and plasmid preparation purposes. 
The chemically competent cells were made from E. coli DH5α and BL21(DE3), respectively. An 
overnight culture of the respective E. coli strain was used to inoculate a 250 ml culture composed 
of Medium A (Appendix III. 1) to an optical density at 600 nm (A600) of 0.1. The culture was 
incubated at 20-25°C in a water bath by shaking at 150 rpm, and cell densities were monitored 
every hour until A600 reached 0.6. The culture was collected in centrifuge tubes and kept on ice 
for 10 min. It was harvested by centrifugation at 2500 g for 10 min at 4°C. The pellet was 
suspended in 80 ml of ice cold Medium B (Appendix III. 1), and incubated on ice for 10 min. 
After a further centrifugation at 2500 g for 10 min, the cells were resuspended in 20 ml of ice 
cold Medium B. Afterward, to this cell suspension 1.4 ml of DMSO was added drop by drop, and 
the mixture was kept on ice for an additional 10 min. Aliquots of 200 µl volume of the competent 
cells were transferred into a chilled sterile 1.5 ml microfuge tube. The cells were frozen with 
liquid nitrogen and were stored at -70°C.  
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8.2.2.2 Preparation of electro-competent cells 
E. coli DH5α electro-competent cell were used for the site directed mutagenesis. An overnight 
seed culture (4 ml) was used to inoculate a 400 ml LB (Difco) main culture, which was grown at 
37°C by shaking at 180 rpm, until the absorbance at A600 reached 0.6. The culture flask was 
incubated on ice for 30 min and subsequently centrifuged at 2000 g for 15 min at 4°C. The 
bacterial pellet was dissolved in 400 ml of ice cold sterile distilled water and centrifuged as 
mentioned before. The pellet was then resuspended in 200 ml of ice cold sterile distilled water 
and centrifuged as before. The resulting bacterial cell pellet was resuspended in 20 ml of ice cold 
sterile 10% glycerol and centrifuged as before. The pellet was finally dissolved in 2 ml of ice 
cold sterile 10% glycerol and was divided into aliquots of 50 µl in microfuge tubes. The tubes 
were immediately frozen in liquid nitrogen and stored at -80°C. The transformation frequency of 
the competent cell was 3 x 1010 cells/ml.  
 
8.2.3 Transformation of E. coli 
8.2.3.1 Heat shock transformation 
Heat shock transformation was applied to introduce the plasmid DNA into the chemically 
competent cells (Sambrook and Russell, 2001). The competent cells were defrosted on ice for 10 
min and mixed with 1 µl (20-100 ng) of plasmid DNA. The mixture was incubated on ice for 30 
min and transferred into a 42°C water bath for 45 sec, followed by incubation on ice for 5 min. 
250 µl of SOC medium (Appendix III. 1) was added to the cells and the mixture was incubated at 
37°C for an additional hour at 180 rpm. 100 µl of the culture were finally plated on LB agar 
plates containing kanamycin (50µg/ml). The plates were incubated at 37°C overnight. 
 
8.2.3.2 Electroporation 
Higher transformation efficiency is generally required for the site directed mutagenesis purpose, 
which can be achieved by using electro-competent cells. In this method, plasmid DNA is 
introduced into bacterial cells by introducing a dielectric breakdown of cell membranes. 
 
Electro-competent cells were thawed on ice and mixed with 2 µl (50 ng) of plasmid DNA. The 
suspension (~100 µl) was transferred to a chilled 0.1 cm electroporation cuvette, which was 
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flicked to remove air bubbles. The cuvette was placed into an electroporator and the electric pulse 
was applied (200Ω and 1.8kV). Cells were immediately resuspended in 500 µl of SOC medium, 
incubated at 37°C for 1 hr and plated on nutrient agar plates containing kanamycin (50 µg/ml). 
 
8.2.4 Site directed mutagenesis 
In order to convert Tyrosine (Y) to Phenylalanine (F) in YXNX motifs of domains 3 and 4 of the 
Mu50 Eap, the Quick-Change Site-Directed Mutagenesis Kit (Stratagene Ltd, Cambridge, UK) 
was used according to manufacturer's instruction. The assay relies on Pfu DNA polymerase 
replicating both plasmid strands with high fidelity. The procedure was started with a PCR 
reaction using a recombinant vector with an inserted gene of interest as template and two 
oligonucleotide primers containing the desired point mutation. The primers were extended during 
temperature cycling by Pfu DNA polymerase. This incorporation of primers generated a mutant 
plasmid containing staggered nicks. The treatment of the amplification product with DpnI 
resulted in the digestion of the parental DNA template. Oligonucleotide primers were designed as 
illustrated in Table 2, introducing the point mutations at amino acid 296 and 403 of the Mu50 
Eap open reading frame, respectively, leading Y to F exchanges in the respective gene products.  
 
Table 3: The reaction components and the PCR conditions employed during the site 
directed mutagenesis. 
Components Volume Components Volume 
plasmid DNA (50 ng) X µl Primer 2 (0.2 µM) 1 µl 
10 x Pfu reaction buffer 5 µl Pfu DNA polymerase 
 (2.5 U/µl) 
0.5 µl 
dNTPs (100 µM each) 2 µl Water (dd H2O) 
Primer 1 (0.2 µM) 1 µl  
Up to 50 µl 
 
 
The mutated plasmids were amplified using the following conditions: 95ºC for 30 sec, followed 
by 20 cycles of 95ºC for 30 sec, 55ºC for 1 min and 68 ºC for 6 min. The final cycle was 25°C for 
2 min. In the case of Mu50 Eap of single domain, the elongation time was reduced to 2 min. 
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After PCR, the samples were placed on the ice for an additional 2 min to cool the reaction to ≤ 
37ºC. 
 
8.2.4.1 Transformation of mutagenesis product  
To remove the unmutated parental DNA, the PCR samples were treated with the restriction 
enzyme DpnI (1 µl) for 1 hr at 37ºC, which cuts only methylated DNA strands. An aliquot of 
electro-competent cells (E. coli DH5α) was thawn on ice, and 2 µl of the DpnI treated plasmid 
sample was mixed with the competent cells. The tube was flicked carefully to mix the sample and 
was incubated on ice for an additional 30 min. After this, the sample was transformed by the 
electroporation method as described above (section 3.2.3.2). After selection of well-isolated 
colonies on an agar plate containing kanamycin, plasmids were extracted and purified as 
mentioned below. The mutations were confirmed by sequencing (4 base-lab, Germany). 
 
8.2.4.2 Plasmid extraction 
The plasmid DNA was purified using the Qiagen Miniprep kit according to manufacturer’s 
instruction. A well isolated colony was picked from a LB-kanamycin plate with a sterile loop and 
placed into 5 ml of LB medium containing kanamycin (50 µg/ml). The culture was incubated 
overnight at 37ºC with an agitation at 230 rpm. The overnight culture (1.5 ml) was transferred to 
a 1.5 ml Eppendorf tube and centrifuged for 1 min at 13,000 rpm. The supernatant was removed 
and the pellet was resuspended in 250 µl of buffer P1, followed by an addition 250 µl of buffer 
P2 (both buffers were provided by the kit). The sample was mixed by inverting the tube for 4 to 6 
times, and lysis was allowed to occur for 2 min. The lysis step was stopped by adding 350 µl of 
the N3 solution (provided by the kit), inverting the tube 4 to 6 times, and incubating the mixture 
for 5 min on ice. The solution was then centrifuged for 10 min at 13,000 rpm at room 
temperature. The supernatant was transferred to a Qiagen column and the tube was centrifuged 
for 1 min at 13,000 rpm. The column was washed with 750 µl of PE buffer (provided in the kit) 
and centrifuged twice to remove the buffer solution. The elution of the DNA was performed by 
adding 50 µl of sterile water to the column and incubating the column at room temperature for 1 
min, followed by a centrifugation at 13,000 rpm for 1 min. The concentration of the plasmid was 
determined by measuring the absorption at 260 nm in a spectrophotometer (Sambrook and 
 41 
Russell, 2001) . The principle of this method is based on the absorption ability of UV light by the 
ring structure of purines and pyrimidines in the DNA or RNA. An aliquot of DNA was send for 
sequencing; the rest was stored at -20°C. 
 
8.2.4.3 Agarose gel electrophoresis 
Agarose gel electrophoresis is an effective method to separate DNA fragments for analytical and 
preparative purposes. The negative charges of DNA molecules help to migrate towards the anode 
in an electrical field. The migration depends on the size (base pair), the conformation of the DNA 
(either relaxed or super-coiled) and also on the pore size of the gel. To detect the DNA, ethidium 
bromide is often used, which intercalates between the stacked base pairs and can be visualized by 
ultraviolet illumination. 
 
For the separation of DNA fragments of 1000 to 8000 bp of length, a 0.8% melted agarose 
solution in 1 x TAE (Appendix III. 3) containing 0.5 µg/ml of ethidium bromide was poured into 
the mold. The solidified gel was transferred into the electrophoresis tank and was covered with 1 
x TAE buffer. DNA samples (5-50 µl) mixed with DNA loading buffer (5:1) (Appendix III. 3) 
were loaded on the gel. To determine the sizes of the DNA fragments, a 1 kb DNA ladder 
(Invitrogen) was loaded on each gel. Electrophoresis was performed at 100 V for 45 min. The gel 
was examined and photographed under by ultraviolet light.  
 
8.2.5 Recombinant Mu50 Eap expression and purification 
8.2.5.1 Heterologous gene expression of His6-Eap 
E. coli strain BL21(DE3) was used as heterologous hosts for the expression of Eap and its 
variants. 100 ng of the respective Mu50 Eap plasmid was mixed with the E. coli competent cells. 
Transformation was carried out by heat shock as described above. The transformation product 
(100 µl) was spread onto a LB plate containing kanamycin and incubated at 37ºC for 24 hr. 
Following this, a well isolated single colony was picked from the plate, inoculated into 10 ml LB 
containing kanamycin (50 µg/ml), and grown overnight at 37ºC with an agitation at 230 rpm. At 
the following day, the main culture was started by diluting the overnight culture 1:100 into 
250 ml of fresh Terrific Broth (TB) (Appendix III. 1) and incubating the mixture at 37°C and 230 
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rpm. When the optical density (A600) of the culture reached 1.0, the protein expression was 
induced by adding isopropyl-β-D-thiogalactopyranoside (IPTG) to a final concentration of 1 mM. 
The culture was grown at 37ºC and 230 rpm for an additional 18 hr to achieve a maximal cell 
density, before the cells were harvested by centrifugation at 5000 rpm. 
 
8.2.5.2 Bacterial cell lysis  
The harvested cell pellets were resuspended in denaturing lysis buffer (5% of the original culture 
volume) and lysed by stirring (Appendix III. 3) at 300–500 rpm for 30 min at room temperature. 
The solubilized-denatured proteins were separated from the cell debris by centrifugation at 
25,000 g for 30 min. 
 
8.2.6 Protein purification 
8.2.6.1 Affinity chromatography  
The affinity chromatography is based on the formation of specific reversible complexes between 
the chromatographic matrix and the molecule of interest. The matrix is represented by a suitable 
polymer, carrying functional group-ligands, which bind the target molecules, whereas all other 
non-specific molecules will pass through the column. In order to purify the proteins of interest, 
the column is first equilibrated with binding buffer. This step is followed by sample loading and 
washing steps, which remove all proteins that are not specifically bound to the matrix. The bound 
molecules are finally eluted from the column either by inducing physico-chemical changes, such 
as the change of ionic strength, pH, temperature, or by adding chaotropic agents like urea, 
ethylene glycol, detergents or ethanol, or by adding a competing substance, such as imidazole.  
 
In this study, protein purification was carried out at room temperature using a fast performance 
liquid chromatography (FPLC) unit (BioRad, Biologic Duo Flow) equipped with a flow cell UV-
vis monitor and a fraction collector. The affinity chromatography was carried out with a Ni2+–
NTA column (GE Healthcare), which exhibits a high binding capacity for histidine-tagged 
proteins. A schematic view on interactions between 6xHis-Tag, Ni2+-NTA, imidazole and EDTA 
with corresponding dissociation constants (Kd) (Knecht et al., 2009) is shown in Figure 8.  
 43 
 
 
Figure 8: An illustration of the interactions that are involved in the purification with a Ni2+-
NTA affinity column. The high-binding affinity between Ni2+ and NTA (Kd value of 10-11 M) 
allows a mild elution with moderate imidazole concentrations (Kd of 10-3 M). The Kd value of 
imidazole is low enough to displace bound 6xHis tags, but is not too high to strip the Ni2+ off the 
column. This can be performed by an injection of EDTA (Kd of 10-11 M) leading to a complete 
recovery of the column material (adapted and modified from Knecht et al., 2009). 
 
8.2.6.1.1 Purification of Eap by denature method  
Affinity chromatography was performed by using a Ni2+–NTA column for FPLC. The clear 
supernatant of the solubilized cell extract was loaded to a 5 ml Ni2+–NTA column joined to 
FPLC, which had previously been equilibrated to room temperature in denaturing wash buffer 
(Appendix III. 3). After loading the sample, non-specifically bound proteins were removed from 
the column by applying 5 column volume (CV) of denaturing wash buffer. The tagged proteins 
were eluted from the resin with 2.5 CV of denaturing elution buffer (Appendix III. 3). During the 
purification, the first 0.5 CV of eluate were discarded since they contained negligible amounts of 
protein. 
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8.2.6.1.2 Protein refolding 
Following the purification under denaturing conditions, the denatured protein samples were 
drawn into an appropriate syringe with a needle, and refolded by quickly injecting the entire 
amount into a 10-fold excess volume of native buffer (Appendix III. 3) at room temperature with 
rapid stirring. The diluted samples were allowed to stir for 5-10 min at room temperature. 
 
8.2.6.1.3 Native purification  
The refolded protein samples were reapplied to the Ni2+–NTA column that had been regenerated 
according to manufacturer’s suggestions and pre-equilibrated with a native wash buffer 
(Appendix III. 3). The excess urea was removed by washing with 5 CV of native wash buffer, 
and the bound, refolded proteins were eluted with 2.5 CV of native elution buffer (Appendix III. 
3). The proteins were concentrated using Amicon Millipore Centricon according to 
manufacturer’s instructions.    
 
8.2.6.2 Gel filtration chromatography 
In gel filtration, samples are loaded on top of a column packed with gels of cross-linked polymers 
with a known pore size, such as dextran. An elution buffer with pH and ionic strength suitable for 
the sample preservation is passed from the top of the column with large molecules being eluted 
faster, as smaller molecules are retarded by the matrix. The speed of elution directly affects the 
effectiveness of the separation with slower speeds giving better resolutions.  
 
In this work, gel filtration was performed using a pre-packed Superdex 75 10/300 column (GE 
healthcare) and the BioRad FPLC system, which should allow separating proteins of molecular 
masses between 3 and 70 kDa. The column was set at room temperature, and prior to the loading 
of the sample, it was washed with 5 CV of phosphate buffer (Appendix III. 3) that had been 
degassed and filtered. During the filtering process, the eluent was analyzed for conductivity, pH 
and UV absorbance, and results were plotted on chromatograms. 200 µl of the concentrated Ni2+–
NTA purified native protein was injected into the FPLC and passed through the Superdex column 
at the rate of 500 µl per min. The sample was passed through a UV detecter at 254 nm and each 
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fraction (500 µl) was collected in a fraction collecter (Biorad). The chromatogram was obtained 
by plotting the changes in UV absorbance (mAU) vs. eluent per sample volume (ml).  
 
8.2.7 Quantitation of endotoxin from purified recombinant Mu50 Eap 
8.2.7.1 Removal of endotoxin from purified Eap 
Endotoxin is an unwanted and often encountered by product of recombinant proteins purified 
from Escherichia coli. The inherent toxicity of endotoxins makes their removal an important step 
for downstream applications of the protein in several biological assays. In this work, putative 
residual E. coli endotoxin contaminating the purified Eap protein fraction was removed using an 
EndoTrap Blue column (Cambrex, Walkersville, MD). The column was charged with 6 CV of 
regeneration buffer (provided by the manufacturer) and equilibrated with 6 CV of equilibration 
buffer (provided by the manufacturer). Following equilibration, the purified Eap protein sample 
was loaded onto the column and allowed to pass through by gravity flow. Fractions were 
collected immediately after the sample was loaded. The collected fractions were concentrated 
using Millipore Centricon as manufacturer’s instruction.  
 
8.2.7.2 Measurement of endotoxin in the purified Eap samples 
The limulus amebocyte lysate (LAL) assay was used to quantify the amount of endotoxin present 
in protein samples following the purification of Eap. The QCL-1000 kit (Lonza) was used 
according to the manufacturer’s instructions.  
 
A standard curve of endotoxin was created ranging from 0.2-1.0 endotoxin units/ml. The purified 
stock of endotoxin was vortexed vigorously for 15 min prior to dilution, and each standard 
dilution was vortexed for an additional two min before transferring it to the next tube. Samples 
were diluted directly in the tube in duplicate, and 10-fold dilutions ranging from pure sample to 
1:1000 were created. Each sample and the standard were prewarmed to 37°C before an 
equivalent amount of LAL reagent was added and incubated for 10 min at 37°C. Chromogenic 
substrate solution was then added to the tubes and incubated for an additional 6 min at 37°C. The 
assay was stopped by the addition of 50 µl of 10% SDS. The absorbance of each sample was 
determined at 405 nm on the spectrophotometer (BioT
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compared to the standard curve of known endotoxin concentrations. The linear regression 
equation of the best fit line through the standard curve points was calculated by Microsoft Excel, 
and then used to determine the endotoxin concentration of the purified protein samples.  
 
8.2.8 Protein quantification 
In this work, protein determination was done either by the Bradford method or by a BCA assay as 
described below.   
 
8.2.8.1.1  Bradford protein assay 
The protein concentrations in the cell culture samples were determined with a Bradford protein 
assay, using bovine serum albumin (BSA) as a protein standard (Bradford 1976). The standard 
curve was made of the readings of eight different dilutions of the stock solution of BSA (1 
mg/ml) with final concentrations of 0, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06 and 0.08 mg/ml, 
respectively. For the protein determination, Bradford solution (Bio-Rad Protein Assay) was 5-
fold diluted in water, and 250 µl were added to the cuvettes containing 10 µl of the standard or 
samples. The solutions were mixed thoroughly and incubated at room temperature for 5 min. The 
respective samples were tested in duplicate, and the absorbance of standard and samples were 
measured using a spectrophotometer (Gene Quantpro) at 595 nm. 
 
8.2.8.2 BCA protein assay  
Protein concentrations were also determined using the BCA (Bicinchoninic Acid) assay protein 
quantitation kit. The principle of the BCA assay is a colorimetric assay which involves the 
reduction of Cu2+ to Cu+ by peptidic bonds of proteins. Bicinchoninic acid chelates Cu+ ions with 
very high specificity to form a water soluble purple colored complex (Figure 9). The reaction was 
measured by the optical absorbance at 562 nm. Protein concentrations were calculated in 
reference to a standard curve obtained with BSA.  
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Figure 9: BC Assay reaction 
 
The working reagent was prepared by mixing 50 volumes of BCA reagent A with 1 volume of 
BCA reagent B (50:1). 100 µl of the standard protein fractions and samples were mixed with 2 ml 
of working reagent, respectively, incubated at 37°C for 30 min, and measured at 562 nm on the 
spectrophotometer (Unicam Helios Instruments). The average absorbance values for the standard 
curve were plotted, and the linear regression equation for the best fit line through the points was 
calculated by Microsoft Excel. Average sample absorbance values in the range of the standard 
curve were interpolated to determine the protein concentration.  
 
8.2.9 Sodium Dodecylsulfate (SDS) polyacrylamide gel electrophoresis (PAGE) 
The discontinuous gel electrophoresis was used to monitor the status of Eap expression and the 
purity of the Eap obtained after several steps of the purification procedure. Proteins were 
separated according to their charge and molecular mass, using Laemmlis’ discontinuous gel 
electrophoresis method (Laemmli, 1970), with a 10 % separating gel (Appendix IV) and a 5% 
stacking gel (Appendix IV).  
 
Briefly, a portion of the Eap protein sample was mixed with 2xSDS loading buffer (Appendix 
IV) (1:1 v/v) and the sample was heated to 100°C for 5 min. After cooling down for 2 min on ice, 
samples were applied to the slots (wells) of the stacking gel and were run for 1 hr and 30 min at 
120 V until the tracking dye (bromophenol blue) front reached to the bottom of the gel. The pre-
stained broad range protein marker (Fermentas life science) served as a reference molecular 
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weight marker. To visualize the protein bands, the gel was stained with Coomassie staining 
solution (Appendix IV) for 30 min at room temperature on a shaker and then incubated in 
destaining solution (Appendix IV), which was changed every 30 min until the protein bands 
became clearly visible.  
8.2.10 Cell culture  
Human keratinocytes were grown and maintained in the keratinocyte growth medium MCBD 153 
basal medium (BIOCROM AG), supplemented with 10% fetal bovine serum (FBS) obtained 
from PAA lab (GmbH), and 1% penicillin /streptomycin (10000U/10000 µg/ml) solution in a 
humid atmosphere containing 5% CO2 and 95% air at 37ºC. All cells were split twice a week. 
Prior to splitting of the cells, they were washed twice with 5 ml PBS (Appendix III. 3). Cells 
were detached from the petri-dishes (10 cm) by adding pre-warmed 1x trypsin-EDTA (2 ml; 
PAA lab GmbH ) and incubated at 37°C with 5% CO2 for 10-15 min and collecting the cells by 
centrifugation. The cells were resuspended into fresh medium and transferred into new petri-
dishes containing fresh medium (10 ml) (cells were diluted by a factor <10). Cell cultures were 
tested routinely for mycoplasma contaminations using the PCR mycoplasma Test Kit 
(AppliChem) according to the manufacturer’s recommendations. 
 
8.2.10.1 Freezing cell lines for long term storage 
After trypsination with pre-warmed 1x trypsin-EDTA and addition of prewarmed MCBD 153 
basal medium, cells were transferred to a falcon tube and centrifuged at 1000 g. In order to 
prevent the formation of ice crystals within the cells, pellets were resuspended in media 
containing 20% DMSO, and were slowly cooled by freezing the cells at –20°C for 1 hr, followed 
by an overnight incubation at –70°C. On the following day, the cells were stored either in a liquid 
nitrogen cell incubator or at –70°C. 
 
8.2.10.2 Determination of cell numbers and cell viability  
Cells were counted by a trypan blue method using the Countless Automated Cell Counter 
(Invitrogen). Cell samples were mixed with trypan blue, loaded into countless cell counting 
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chamber slides (Stuart Scientific Colony Counter), and applied to the cell counter, thereby 
determining the live/dead ratio of cells and the total cell concentration per milliliter. 
 
8.2.11 Cell culture assays 
8.2.11.1 Adherence assay  
The adherence and internalization assay was performed as described by Haggar et al., (2003) 
with slight modifications. Briefly, HaCaT cells were seeded (1x105cells/well) into 24-well plates 
and incubated at 37°C in presence of 5% CO2 until the cell layer reached confluence. Cells were 
washed with PBS (Appendix III. 3), and 300 µl of standard medium supplemented with the 
purified Eap samples (WT and mutant samples) at a concentration of 30 µg/ml (final 
concentration) were added. The cultures were incubated for 1 hr and washed with PBS as 
described above. 300 µl of fresh standard medium containing 107 bacteria (multiplicity of 
infection of 100) were added per well. After additional 2 hr and 30 min of incubation, media 
were removed and wells were washed three times with PBS to remove non-adherent bacteria. In 
the next step, 200 µl of trypsin/EDTA were added per wells to detach the cells, which were 
subsequently lysed by the addition of 800 µl of sterile water, and sonicated at 75 watt for 15 sec. 
The bacteria were serially diluted and plated on MHA plates. After 24 hours of incubation, 
colonies were counted, and CFUs were determined. 
 
8.2.11.2 Internalization assay 
For the internalization assay, the adhesion assay protocol was followed with the one exception 
that after incubation for 2 hr and 30 min, the old media were replaced by adding 200 µl of fresh 
media containing lysostaphin (20 µg/ml final concentrations) and the cell cultures were incubated 
for an additional hr.  
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8.2.11.3 ERK phosphorylation assay 
8.2.11.3.1 Cell assay for ERK signaling 
The ERK phosporylation assays were performed essentially as described (Sobke et al., 2006). 
Briefly, HaCaT cells were seeded into 6 well plates with a cell-density of 2x106cells/well, and 
cultured for 24 hr in MCBD 153 containing 10% FBS and 1% penicillin/streptomycin. After this 
incubation, old media were replaced by fresh medium containing 0.5% FBS and further 
incubated overnight. On the following day, old media were replaced by basal medium containing 
0.05% BSA (Sigma), and the cells were incubated for additional 4 hr before Eap was added. 
After an additional hr of incubation, ERK phosphorylation was induced by adding keratinocyte 
growth factor (KGF) at a concentration of 50 ng/ml and incubating the culture for 8 min. After 
that, cells were washed twice with ice-cold PBS, lysed on ice in RIPA buffer (Appendix V)  and 
then centrifuged at 10,000 g for 10 min at 4ºC to remove all insoluble material. The supernatants 
were collected and total cellular protein contents were determined using Bradford and BCA 
assays. Equal amounts of protein (30 µg) were subjected to Western blot analyses using anti-
phospho-ERK (Thr202/Tyr204) antibodies.  
 
8.2.11.3.2 Western blot of ERK signaling 
Proteins were transferred from the SDS-gel onto a nitrocellulose transfer-membrane (Protran®, 
Whatman) by a semi-dry blotting method in a BioRad Transfer-blot SD system using the 
manufacturers protocols. The blots were subsequently blocked for 1 hr with 5% skim milk in 
Tris-buffer saline (Appendix III. 3) supplemented with 0.1% Tween 20, followed by an overnight 
incubation at 4°C with a 1:1000 dilution of anti-phospho-ERK (Thr202/Tyr204) antibody 
purchased from Cell Signalling Technology (Beverly MA). On the following day, membranes 
were washed 3-times with TBS, followed by incubation at 25°C for 1 hr with a 1:4000 dilution of 
the secondary antibody, a horseradish peroxidase-conjugated anti-mouse IgG antibody (Biorad). 
After additional three rounds of washing, blots were equilibrated in detection buffer, overlayed 
with an ECL solution (Amersham Bioscience) and incubated for 2 min. at RT, before the 
chemiluminescence signals were captured using a ChemiDoc XRS-system -system (BioRad).  
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8.2.11.4 Proliferation assay 
HaCaT cell (2x103 cells per 100 µl) were seeded into 96 well plates in a MCBD 153 medium 
supplemented with 0.5% fetal bovine serum and incubated at 37ºC for 24 hr in a humid 
atmosphere containing 5% CO2 and 95% air. Afterwards, the old media were replaced by fresh 
media containing 0.2% BSA and 30 µg/ml of Eap and further incubated for a night. On day three, 
cells were incubated with EdU (ethynyl-2- deoxyuridine) at a concentration of 10 mM and 
incubated for 24 hr. On day four, the EdU incorporation was measured with the Click-iT-EdU 
Microplate Assay kit (Invitrogen). All samples were assayed in triplicate. Fluorescence signals 
were measured with the Wallac Victor-2 microtiter well plate reader (Perkin Elmer Life Science) 
at excitation/emission wavelengths of 490/510 nm. 
 
8.3 Statistical methods 
An unpaired two sided Mann Whitney U test was used, with a threshold of statistical significance 
assumed at P values of <0.05 (*) and <0.01 (**). 
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9 Results 
9.1 Bioinformatics study  
All S. aureus strains tested to date produce Eap, which varies considerably in its size between 
different isolates. The protein is usually composed of 4 to 6 tandem repeats, with only few 
exceptions. In this study, the amino acid sequences of Eap from 14 different strains of S. aureus 
were retrieved and a multiple sequence alignment was performed as described in the ‘Methods’ 
section. The alignment result is shown in Appendix I. 3.  
 
Based on the sequence alignment of the Eaps, five different Eap domain-types were identified 
(type I, II, III, IV and V). The corresponding sequence alignments of the domains are shown in 
Figure 10-14 and their comprehensive diagrammatic representation is shown in Figure 15. S. 
aureus stains having small variants of this protein were composed of Eap domain types that were 
not redundant, while the larger Eap variants usually contained repeats of one or two domain 
types, with the domain types 3 and 4 being duplicated in most of the cases. For example, the Eap 
of S. aureus strain Mu50 is composed of four domains: domain 1 of type I, domain 2 of type II, 
domain 3 of type III, and domain 4 of type IV. The Eap of strain RF122 is composed of three 
domains; domain 1, domain 2 and domain 3. The alignment of each domain with respect to the 
strain Mu50 showed the presence of type I, type II and type IV domains, respectively, in which 
the domain 3, though being third domain, showed the highest identity/similarity with type IV 
(Table 4). Similarly, the Eap of strain Wood 46 is composed of 6 domains; domain 1 (type I), 
domain 2 (type II), domain 3 and domain 4 (both type III), and domain 5 and 6 (both type IV), 
suggesting a duplication of these two domains during the evolutionary process of the strains. 
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Table 4: The comparative study of the individual domain of S. aureus strain RF122 with respect 
to the strain Mu50. The pairwise sequence alignment was performed to find the 
identity/similarity of the individual domain. The domain 1 (D1), domain 2 (D2) and domain 3 
(D3) of RF122 showed the highest identity/similarity with type I, type II and type IV domains 
with respect to the strain Mu50, and the values are shown in bold. 
Identity/Similarity  
S. aureus strain RF122 
Mu50 D1 D2 D3 
D1 (Type I) 85.2/95.5 84.1/95.5 56.8/77.3 
D2 (Type II) 83.0/95.5 97.7/98.9 60.2/79.5 
D3 (Type III) 53.4/77.3 51.1/76.1 60.2/75.0 
D4 (Type IV) 62.5/78.4 62.5/76.1 92.0/97.7 
 
The sequence alignment also revealed that the putative tyrosine phosporylation sites of Eap 
identified by S. Kerdudou (unpublished PhD thesis), the YXNX motifs, were more or less 
conserved in the Eap domain types I, III and IV (Figure 10-15), whereas they were absent in 
domain types II and V. The highest conservation of the YXNX motif was found in the domain of 
type III, which was present in all strains harboring this type followed by the domain type IV, 
where the YXNX motif was found in 12 out of 14 isolates (Figure 15). However, the YXNX 
motif was less conserved in the domain type I, being present in 10 of the 14 analyzed isolates 
only (Figure 15). Interestingly, Eap variants that are composed of more than four repeats did not 
show the conserved YXNX motifs in all the duplicated type III and IV domains (Figure 15). 
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Figure 10: The Clustal W2 alignment of the amino acid sequences of Eap domain type I 
from fourteen different strains of Staphylococcus aureus species. The 14 different strains of S. 
aureus Eap include Mu50 (SAV1938), RF122 (SAB1873c), N315 (SA1751), JH9 (A5IUA7), CI-
7 (AJ243790), USA300 (ABX29943), MSSA476 (SAS1861), MW2 (EFK80959.1) , 8325 
(ABD31208), COL (AAW36971), FDA547 (Q53599), Newman mapN (AJ132841), MRSA252 
(SAR2030) and Wood46 map-W (AJ245439). The conserved -YXNX- motif of domain type I is 
represented in red. The diagrammatic representation of the conserved domain with its domain 
type is illustrated in second part of this figure (Figure 15). 
 
 
Figure 11: The Clustal W2 alignment of the amino acid sequences of Eap domain type II 
from fourteen different strains of Staphylococcus aureus species as mentioned in Figure 12. 
There is no conserved -YXNX- motif in domain type II. The diagrammatic representation of the 
conserved domain with its domain type is illustrated in second part of this figure (Figure 15). 
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Figure 12: The Clustal W2 alignment of the amino acid sequences of Eap domain type III 
from fourteen different strains of Staphylococcus aureus species as mentioned. The 
conserved -YXNX- motif of domain type III is represented in red. The diagrammatic 
representation of the conserved domain with its domain type is illustrated in second part of this 
figure (Figure 15). 
 
 
Figure 13: The Clustal W2 alignment of the amino acid sequences of Eap domain type IV 
from fourteen different strains of Staphylococcus aureus species as mentioned. The 
conserved -YXNX- motif of domain type IV is represented in red. The diagrammatic 
representation of the conserved domain with its domain type is illustrated in second part of this 
figure (Figure 15). 
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Figure 14: The Clustal W2 alignment of the amino acid sequences of Eap domain type V 
from fourteen different strains of Staphylococcus aureus species as mentioned. There is no 
conserved -YXNX- motif in domain type V. The diagrammatic representation of the conserved 
domain with its domain type is illustrated in second part of this figure (Figure 15). 
 
 
 
 
Figure 15: Distribution of the Eap domain types in 14 different Staphylococcus aureus 
strains. The domain type I (red), type II (magenta), type III (blue), type IV (green) and type V 
(purple) are shown. The type I, type III and type IV domain have conserved -YXNX- motifs, in 
which (Y) is tyrosine, (N) is asparagine and X is variable. 
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9.2 Selection of Mu50 Eap and generation of its derivatives  
In this work, we focused mainly on the Eap of S. aureus strain Mu50 (Mu50 Eap) for the 
following reasons: The Eap of strain Mu50 is well characterized and shown to be functional 
(Geisbrecht et al., 2005; Hammel et al., 2007). Moreover, it harbors three YXNX motifs in the 
domain types I, III, and IV. Interestingly, it also lacks the duplications of the domain types found 
in other derivatives, thereby reducing the workload to mutate all YXNX motifs present in the Eap 
of interest. Additionally, the expression-plasmids harboring the wild type of Mu50 Eap and all 
single domains were already available (Geisbrecht et al., 2005), which accessed us to create 
desired  mutations in the constructs. 
  
In addition, the amino acid tyrosine is an important site for the phosphorylation which might play 
an important role during cell signaling. The phosphorylation of tyrosine can modulate the 
functional activity and/or promote interaction with other molecules (Schlessinger, 2000). As a 
result, in this study we speculated that the phosphorylation of tyrosine residues in the conserved 
YXNX motifs might play an essential role for Eap functions. 
 
In reference to the above mentioned experimental and theoretical assumptions, the tyrosine 
residues of the conserved YXNX motif in domains 3 and 4 of Mu50 Eap were mutated to 
phenylalanine at Y296F and Y403F, respectively, with the mutagenic primers mentioned in Table 
2. The point mutations were done for the full-length (FL) Mu50 Eap, and for single, double, and 
triple domain constructs as depicted in Figure 16 and Appendix I.1). As a result of our 
mutagenesis attempts, eight mutants were created having point mutations leading to tyrosine to 
phenylalanine exchanges in the FL Eap of domain 3 (FLD3) and domain 4 (FLD4), the domains 
2 to 4 containing fragments 2L4 mutated in domain 3 (2L4D3) and domain 4 (2LD4), the 
domains 3 and 4 containing fragments 3L4 mutated in domain 3 (3L4D3), and domain 4 
(3L4D4), and the single domain 3 mutant (D3M) and domain 4 mutant (D4M). All mutations 
were confirmed by sequencing (see Appendix I. 2). 
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Figure 16: Schematic representation of the Mu50 Eap wild-type and its mutants used in this 
study. Eight Eap mutants were constructed by exchanging Tyrosine (T) to phenylalanine (F) in 
the putative YXNX motifs of domains 3 and 4, respectively. The asterisk ‘*’represents the point 
mutation that has been introduced. 
 
9.3 Heterologous expression of the recombinant wild-type and mutant Mu50 Eaps  
E. coli strain BL21(DE3) was used as a heterologous hosts for the expression of the Mu50 Eap 
and its different mutant derivatives. The Mu50 FL eap sequence and the different Mu50 Eap 
fragments were sub-cloned into the plasmid pT7HMT (Geisbrecht et al, 2005) into the SalI/NotI 
restriction sites (Appendix I.1).  
 
In order to determine the optimal conditions for the production of large amounts of the 
recombinant proteins, expression trials were performed using 5 ml cultures of the transformed E. 
coli host cells. The yield of the protein expression was first tested in the E. coli strain 
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BL21(DE3)pLys but the expression was very low in this expression host. Therefore, we used 
strain BL21(DE3) to optimize the expression conditions. The addition of the inducer IPTG to the 
bacterial culture at different growth stages identified an A600 of 1 as the best induction time-point. 
These studies also revealed that a high shaking speed (230 rpm) and a culture/flask volume of 
1:10 were beneficial for a high Eap expression yield. In addition, an incubation temperature of 
37°C was found to be the best temperature for the expression of this protein.  
 
The recombinant proteins of all Eap constructs were expressed accordingly, and whole cell 
extract fractions of the uninduced and induced cultures were tested on SDS-PAGEs to confirm 
the over-expression of Eap and its derivatives. The representative picture for the Mu50 FL Eap is 
shown in Figure 17.  
 
 
Figure 17: Heterologous expression of the wild-type Mu50 Eap. Coomassie blue-stained SDS-
PAGE of Mu50 Eap wild-type protein. Lane 1 - prestained protein ladder (Fermentas), lane 2 - 
before induction, lane 3 – after induction (18 hr). The numbers in the column represents the 
molecular weight (kDa) and the arrow denotes the expression of the target protein (∼60 kDa)  
 
After optimizing the expression conditions, large scale batch cultures were carried out in 2 L 
culture flasks following the growth conditions as mentioned above. The cells were harvested and 
were stored at -20°C until purification. 
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9.4 Purification of the wild-type and mutant recombinant Mu50 Eap 
The purification of the recombinant Eap derivatives of S. aureus Mu50 was performed by affinity 
chromatography (Ni2+-NTA column) followed by size exclusion chromatography (superdex-75) 
using a FPLC (fast performance liquid chromatography) unit (BioRad) equipped with a fraction 
collector. The system simultaneously analyzes the eluent for conductivity, pH and UV 
absorbance. The working pressure of the column was below 40 psi.  
 
In the first step of the purification, the supernatants of cell lysates were applied to a Ni2+-NTA 
column under denatured condition, and the hexahistidine-tagged proteins were eluted following a 
single, stringent washing step (Figure 18; data for FLD4 shown). Purifying proteins under 
denatured conditions has several advantages, as it helps to stabilize labile proteins by inactivating 
proteolytic enzymes which might be present in the crude sample extracts, and it also reduces the 
binding of contaminating proteins to the resin. 
 
 
Figure 18: Denature purification of the Mu50 Eap protein. A. FPLC chromatogram of the 
Mu50 full-length domain 4 (FLD4) mutant by Ni2+-NTA affinity chromatography. The tube 
numbers on top represent the collected fraction during purification. The x-axis and y-axis 
represent the absorbance at 280 nm and time (min), respectively. The peak at tubes 22 and 23 is 
the major purified fractions of Mu50 Eap (FLD4). B. SDS-PAGE of fractions 21 to 28 of the 
Mu50 Eap FLD4 collected from Ni2+-NTA affinity chromatography. The arrow represents the 
target protein. The ‘M’ represents the prestained protein ladder (Fermentas) and BSA (bovine 
serum albumin) is used as a control. 
 
Following the initial denatured purification step, the Eap proteins were refolded in a native buffer 
and reapplied to a Ni2+-NTA column that was pre-equilibrated with native wash buffer. After 
washing, the proteins were eluted by a native elution buffer, and fractions were collected using 
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the fraction collector. Aliquots of each fraction were applied to SDS-PAGE to identify the 
fraction containing the highest concentration of the protein of interest (Figure 19; data for FLD4 
shown).  
 
 
Figure 19: Native purification of Mu50 Eap protein. A. FPLC chromatogram of the Mu50 
full-length domain 4 (FLD4) mutant by Ni-NTA affinity chromatography. The tube numbers 
on top represent the collected fraction during purification. The x-axis and y-axis represent the 
absorbance at 280 nm and time (min), respectively. B. SDS-PAGE of the Mu50 FL D4 mutant 
fractions 22 to 27 obtained by the Ni-NTA affinity chromatography. The arrow represents the 
target protein. The ‘M’ represents the prestained protein ladder (Fermentas). 
 
In the next step, fractions of interest were pooled and concentrated to the final volume of 
approximately 2-3 ml using 10 kDa and 30 kDa cutoff centricons (Amicon Millipore), 
respectively, according to the molecular weight of the recombinant Eap proteins (full-length and 
fragments). In the last step, the concentrated proteins were applied to a Superdex-75 column 
(Figure 20; data for FLD4 shown).  
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Figure 20: A. Purification of Mu50 full-length Domain 4 (FLD4) mutant by size exclusion 
chromatography. The tube numbers on top represent the collected fraction during purification. 
The x-axis and y-axis represent the absorbance at 280 nm and time (min), respectively. B. SDS-
PAGE of Mu50 FLD4 mutant. Lane 2 to 12 represents the respective fractions (12 to 21) 
collected during the size exclusion chromatography. The low molecular bands present in the 
fractions were either impurities or degraded Eap. The arrow represents the target protein. The 
‘M’ represents the prestained protein ladder (Fermentas). 
 
The eluted fractions were again collected into different tubes, pooled and concentrated as 
mentioned before, and the protein contents of the concentrated samples were determined by the 
BCA method. The purified Mu50 Eap derivatives are shown in Figure 21 and Table 5, 
respectively.  
 
 
Figure 21: SDS-PAGE of purified Mu50 Eap derivatives. A. lane 1: marker; lane 2: two 
domains having domain 3 and 4 fragment wild-type (3L4 WT); lane 3: two domains having 
domain 3 and 4 fragment with the mutation in domain 3 ( 3L4D3), lane 4: two domains having 
domain 3 and 4 fragment with the mutation in domain 4 ( 3L4D4), lane 5: full-length wild-type 
(FLWT),  lane 6: full-length domain 3 mutant (FLD3 ), lane 7: full-length  domain 4 mutant 
(FLD4). B. lane 1: marker, lane 2: single domain 3 wild-type (D3WT), lane 3: single domain 3 
mutant (D3M), lane 4: single domain 4 wild-type (D4WT), lane 5: single domain 4 mutant 
(D4M). 
 63 
9.5 Endotoxin purification 
The endotoxin LPS (lipopolysaccharide), generated by Gram-negative bacteria such as E. coli, is 
toxic to eukaryotic cells and may have severe inhibitory effects in eukaryotic cell assays. 
However, endotoxin concentrations below 0.1 endotoxin units (EU) per µg protein are considered 
to be non effective in cell culture assays. Since LPS contaminations are frequently encountered in 
protein samples obtained from E. coli cultures, all Eap proteins were purified by using EndoTrap 
Blue columns (Cambrex, Walkersville, MD) as described by the manufacturer, and the residual 
endotoxin contents of the samples were subsequently tested using the limulux test system 
(Lonza). After the EndoTrap purification step, all samples showed endotoxin concentrations that 
were below 0.0032 EU per 30 µg of protein (Table 5).  
 
Table 5: Protein and endotoxin concentrations of Mu50 Eap samples. The concentrations of 
the different Mu50 Eap wild-type and mutant protein samples were identified by the BCA 
method after size exclusion chromatography and endotoxin purification. The amount of 
endotoxin was calculated for 30 µg of the corresponding Eap sample.  
 
 
Mu50 Eap 
Conc. of 
Eap 
(µg/µl) 
Conc. of 
endotoxin 
(EU/ml) 
Conc. of 
endotoxin per 30 
µg of  protein 
(EU/30 µg) 
 FL WT 0.958 0.104 0.0032 
FLD3 mutant 1.858 0.088 0.0014 
FLD4 mutant 1.684 0.072 0.0012 
3L4 WT 1.733 0.050 0.0008 
3L4 D3 mutant 2.219 0.090 0.0012 
3L4 D4 mutant 1.519 0.009 0.0001 
D3 WT 2.06 0.059 0.0008 
D3 mutant 2.26 0.067 0.0008 
D4 WT 1.838 0.077 0.0012 
D4 mutant 1.764 0.102 0.0017 
 
 64 
9.6 Cell culture experiments 
9.6.1 Adherence assay 
Previous studies showed that externally added Eap of strain Newman could enhance the binding 
of S. aureus to fibroblasts and epithelial cells (Hussian et al., 2008). However, the effect of the 
wild-type and mutated Eap of Mu50 in the adherance of S. aureus has not been studied so far. 
Therefore, in this study, we examined the role of externally added Eap and its derivatives on the 
adherence of S. aureus SA113 to HaCaT keratinocyte cells. HaCaT cells grown to confluency 
were inoculated with 30 µg/ml of the Eap samples and incubated for 1 hr. After the Eap 
treatment, cells were washed with PBS to remove unbound Eap, and subsequently inoculated 
with S. aureus SA113 with an MOI of 100, and incubated for 2 hr 30 min. After the second 
incubation step, cells were trypsinized, sonicated, and the lysates were plated on agar plates to 
determine the colony forming units representing the adherent (Figure 22) and internalized 
bacteria. 
 
 
 
 
Figure 22: Adherence of bacteria to keratinocytes after the preincubation with Eap. 
Confluent layers of keratinocytes were incubated for 1 h with 30 µg/ml of the (A) FLWT, FLD3, 
FLD4; (B) 3L4WT, 3L4D3, 3L4D4; (C) D3WT, D3M, D4WT and D4M, of the Mu50 Eap, 
washed with PBS, inoculated with strain SA113 (MOI of 100) and incubated at 37°C for 2 hr and 
30 min. Bacteria were detached and viable counts were determined. Data represent the means and 
the error bars show standard deviation of 3 independent experiments performed in duplicate. 
Statistical significances between the wild-types and their derivatives were determined using the 
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Mann-Whitney U-Test. P values of individual wild-types versus their mutants were <0.05 (∗) and 
<0.01 (∗∗). 
 
This assay revealed a clear difference between wild-type and mutant proteins in terms of 
adherence of bacteria to keratinocytes. In correlation with previous findings (Hussian et al., 
2008), we detected an increased adherence of S. aureus to keratinocytes after preincubation of the 
eukaryotic cells with the full-length wild-type Eap (FL) (P<0.01) (Figure 22. A). Incubating the 
HaCaT cells with the two-domain 3 and 4 fragment of Eap (3L4WT) also increased the binding 
of S. aureus to the keratinocytes (P<0.05) (Figure 22. B), although this effect was not as 
pronounced as that observed with the full-length protein. However, treating the keratinocytes 
with the single domains 3 and 4, respectively (Figure 22. C) did not alter the binding capacity of 
S. aureus to the HaCaT cells, indicating that at least a tandem repeat of the Eap domains is 
required for this effect.  
 
Interestingly, treating HaCaT cells with the FLD3 and FLD4 mutant proteins showed a decreased 
adherence of S. aureus to the eukaryotic cells, if compared to the wild-type FL protein, and this 
decrease in adherence was found to be more pronounced with the full-length protein being 
mutated in domain 4 (P<0.01) (Figure 22. A). Similarly, treating the HaCaT cells with the two 
domain Eap fragment with the mutation in domain 4 (3L4D4) yielded a less pronounced increase 
in adhesion of SA113 to the keratinocytes than incubating the eukaryotic cells with the wild-type 
fragment (3L4WT) (Figure 22. B). However, no such effect was observed with the two-domain 
fragment being mutated in the YXNX motif of domain 3, which induced an increase in adhesion 
that was comparable to the wild-type fragment. Like the single domains D3WT and D4WT 
neither the mutated variant D3M nor D4M showed the change in the binding capacity of S. 
aureus to the HaCaT cells (Figure 22. C). 
 
9.6.2 Internalization assay 
The Eap-stimulated attachment of S. aureus to fibroblast and epithelial cells is also reported to 
increase the internalization of the bacterium into the eukaryotic cells for strain Newman (Hussain 
et al., 2008). Thus, we were curious whether and how the mutations of Eap could sustain this 
effect. Consequently, we carried out an internalization assay that essentially mimicked the 
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adhesion assay described above, with the expectation that all attached but not internalized 
bacteria were lysed by lysostaphin treatment after the second incubation period. The level of 
internalization was again determined by assaying the colony forming units on agar plates (Figure 
23).  
 
 
 
 
Figure 23: Internalization of bacteria to keratinocytes after preincubation with Eap. 
Confluent layers of keratinocytes were incubated for 1 hr with 30 µg/ml of the (A) FLWT, FLD3, 
and FLD4; (B) 3L4WT, 3L4D3 and 3L4D4; (C) D3WT, D3M, D4WT and D4M, of the Mu50 
Eap, washed with PBS, inoculated with strain SA113 (MOI of 100) and incubated at 37°C for 2 
hr and 30 min. To eliminate adherent bacteria, wells were further incubated with lysostaphin to 
kill the extracellular bacteria. Cells were detached and lysed, and bacterial viable counts were 
determined.  Data represent the means and the error bars show standard deviation of 3 
independent experiments performed in duplicate. Statistical significances between the wild-types 
and their derivatives were determined using the Mann-Whitney U-Test. P values verses the 
control were <0.01 (∗∗) and <0.05 (∗).  
 
Similar to the adhesion assays, we also observed clear differences in the internalization assays 
after the incubation of keratinocytes with the WT- and mutated-Eaps. The preincubation of the 
HaCaT cells with the full-length Eap protein yielded an almost 7-fold increase in internalization 
of SA113 into this cell type (P<0.01) (Figure 23. A). However, the treatment of HaCaT cells with 
the mutated full-length proteins FLD3 and FLD4, significantly lower the internalization of 
SA113 into the keratinocytes if compared to the wild-type protein (P< 0.01) (Figure 23. A). Once 
again, we observed that the mutation in domain 4 seemed to inhibit the stimulative effect of the 
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Eap more than the mutation of domain 3. Similarly, by incubating the HaCaT cells with the two-
domain fragments, the strongest increase in invasiveness was observed with the unmutated 
fragment, 3L4WT (P<0.01) (Figure 23. B), followed by the domain 3 mutant, while the domain 4 
mutant 3L4D4 showed the smallest effect. In comparison to the full-length protein (FLWT), the 
3L4WT fragment was less effective (P<0.05) in inducing the internalization of SA113 into 
keratinocytes. No differences in invasiveness were observed after the treatment with the single 
mutant derivatives (Figure 23. C), which did not seem to stimulate the uptake of bacteria by the 
eukaryotic cells.    
 
9.6.3 ERK phosphorylation assay 
Eap was shown to interfere with the ERK phosphorylation pathway in endothelial cells (Sobke et 
al., 2006). To discern whether the activation of the ERK pathway is inhibited or reduced by Eap 
in HaCaT cells, we explored the phosphorylation of ERK 1/2 in response to Eap. For this 
purpose, lysates of HaCaT cells, which were stimulated with 50 ng/ml of keratinocyte growth 
factor (KGF) were immunoblotted with a phosphospecific antibody directed against the activated 
forms of ERK 1/2 (phosphos Thr202/Tyr204). Similar to the observed results in endothelial cells 
(Sobke et al., 2006), we detected an increase in ERK phosphorylation in keratinocytes upon 
stimulation with the cognate growth factor, in which the treatment of HaCaT cells with KGF (50 
µg/ml) showed an increased phosphorylation of ERK 1/2 with a maximum at 8 min after the 
addition of the growth factor (Figure 24).  
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Figure 24: Effect of Eap on KGF induced ERK phosphorylation. Serum deprived HaCaT 
cells were left untreated or incubated with different Mu50 Eaps; (A) FLWT, FLD3 and FLD4, 
(B) 3L4WT, 3L4D3 and 3L4D4  (C) D3WT, D3M, D4WT and D4M, of Mu50 Eap (30 µg/ml of 
each) for 1 hr before the ERK phosphorylation was induced with 50 ng/ml KGF for 8 min. After 
cell lysis, 30 µg of total cell protein per lane were analysed by SDS-PAGE on a 10% gel and used 
for Western blot analysis with antibodies specific to the phosphorylated form of ERK 1/2. 
Densitometric evaluation of the ERK 1/2 phosphorylation signals normalized against the 
phosphorylation signal in the uninduced control (-KGF). Data represent the means and the error 
bars show the standard deviation of 3 independent experiments performed in duplicate. P values 
verses the control (KGF) were <0.05 (∗) and <0.01 (∗∗). 
 
Similar to the situation observed for endothelial cells (Sobke et al., 2006), we found that the 
preincubation of keratinocytes with the wild-type Eap (FLWT) largely allowed to suppress the 
KGF-induced ERK phosphorylation (P<0.01). Interestingly, preincubating the HaCaT cells with 
the mutated full-length Eap derivatives FLD3 (P<0.01) and FLD4 (P<0.05) reduced the KGF-
stimulated phosphorylation of ERK to a similar extent as the wild-type Eap (Figure 24. A), and 
the same effect was observed for the two domains Eap fragment protein 3L4WT and its mutant 
variants 3L4D3 and 3L4D4, which suppressed the KGF-stimulated phosphorylation of ERK 
(Figure 24. B). The treatment of the cells with single domain variants D3 and D3M of Eap, on the 
other hand, did not show any interference with the KGF triggered ERK1/2 phosphorylation, 
while the domain 4 variants (D4 and D4M) showed a slightly increase in ERK1/2 
phosphorylation of the keratinocytes, although this was not statistically significant (Figure 24. C). 
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9.6.4 Proliferation assay 
A previous study indicated that Eap affects the proliferation of peripherial blood mononuclear 
cells (PBMCs) in a concentration-dependent manner (Hussain et al., 2008). Since we were also 
interested to see the effect on the growth factor stimulated proliferation of keratinocytes, we 
assayed the KGF response of HaCaT cells in presence and absence of Eap by using an EdU 
incorporation test.  
 
We first determined the impact of the Eap concentration on HaCaT cell proliferation (Figure 25). 
For this purpose, HaCaT cells were incubated for 24 hr with the increasing concentration (2.5 to 
100 µg/ml) of the full-length wild-type Eap, before the cells were treated with 10 mM EdU. 
HaCaT cells incubated with 2.5 µg/ml of Eap seemed to display a slight increase in proliferation, 
however, this was not statistically significant. Incubating the keratinocytes with higher 
concentration of the Eap (5-100 µg/ml), on the other hand, reduced the proliferation in a dose 
dependent manner, and this effect became statistically significant with concentrations above 10 
µg/ml. Keratinocytes incubated with a proteinase K treated Eap sample showed a proliferation 
rate similar to the KGF-stimulated control, confirming that this effect is indeed Eap-dependent. 
 
 70 
 
 
Figure 25: Proliferation of HaCaT cell in the absence/presence of increasing concentrations 
of Mu50 FL WT Eap. The HaCaT cells were treated without and with increasing concentration 
of Mu50 Eap FL. The value indicated below each bar represents the concentration of Eap used. 
The cells were treated with 10 mM EdU and the proliferation of the cells was measured by a plate 
reader. Data represent the means and the error bars show standard deviation of 2 independent 
experiments performed in duplicate. The P value verses the control (KGF) was <0.01 (∗∗). 
 
In the second step, the effect of the Eap derivatives was tested (Figure 26). HaCaT cells that were 
treated with keratinocytes growth factor showed a 100% proliferation after 24 hr of growth, 
whereas the cells that were treated with the full-length Eap derivatives (FLWT, FLD3, and 
FLD4) and the domains 3 and 4 fragment derivatives (3L4WT, 3L4D3, and (3L4D4) showed a 
reduced proliferation, which was below 55% (P<0.01). In addition,  HaCaT cells incubated with 
the single domain Eap variants (D3WT, D4WT, D3M and D4M) were less efficient in reducing 
the proliferation rates in comparison with the full-length and two domain derivatives, although 
the proliferation rates were still below the control cells that were treated with only KGF 
(P<0.05). However, no apparent differences in proliferation were observed between the 
keratinocytes that were treated with the wild-type Eaps and their mutant variants.  
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Figure 26: Proliferation of HaCaT cell in the presence of the Eap derivatives. The HaCaT 
cells were incubated for 24 hr with KGF and with Eap samples; FLWT, FLD3, FLD4, 3L4WT, 
3L4 D3, 3L4D4, D3WT, D3M, D4WT and D4M of Mu50 Eap (30 µg/ml of each). After that, 
cells were treated with 10 mM EdU and the proliferation of the cells was measured by a plate 
reader at 490/510 nm. Proliferation of HaCaT was expressed as percentage of the untreated 
control. Data represent the means and the error bars show standard deviation of 4 independent 
experiments performed in duplicate. P values verses the control (KGF) were <0.01 (∗∗) and 
<0.05 (∗). 
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10 Discussion 
Staphylococcus aureus is a one of the leading etiological agent for nosocomial infections and a 
number of community borne diseases. The extracellular adherence protein (Eap), a member of the 
family of SERAM, is one of the potent virulence factors, which is exclusively present in all S. 
aureus strains analyzed to date. This protein is known to exhibit a broad spectrum of binding 
capacities, and was shown to interfere with host cell signaling processes. Especially the latter 
properties of Eap, together with the observation that this protein harbors conserved YXNX 
motifs, which are discussed as potential tyrosine phosphorylation sites in a couple of eukaryotic 
proteins, led us to the assumption that Eap might be subject to tyrosine phosphorylation, which in 
turn may alter the activity of this protein. Here, we report about the construction and 
characterization of Eap mutants derived from strain Mu50, in which tyrosine residues of the 
conserved YXNX motifs of domains 3 and 4 were changed to phenylalanine.   
 
10.1 Selection and study of Mu50 Eap domain containing conserved motif 
The comparison of the amino acid sequences of the Eap domains derived from fourteen different 
strains of S. aureus identified five types of domains (designated as type I to V). In this study, we 
focused on the Eap of strain Mu50, which is composed of four Eap domains of type I, II, III, and 
IV. It is believed that the variation in the tandem repeats of Eap domain could be due to the 
duplication from the original single monomer during evolutionary processes. 
 
During the Eap sequences analysis, we found that only the domain types I, III and IV contained 
YXNX motifs, with the YXNX motif of domain type III being the most conserved motif, 
followed by the YXNX motif of domain type IV (Figure 10-15). Moreover, the pronounced anti-
angiogenic activity observed with domain 3 and 4 (type III and IV) fragments of Eap from strain 
Mu50, respectively, highlighted the importance of these domains (K.  T. Preissner, unpublished 
data). In addition, the solved crystal structure of Mu50 Eap (Geisbrecht et al., 2005) also provides 
detailed structural information for this protein. Therefore, our study focused on the Eap of strain 
Mu50. Here, different mutated derivatives of the Mu50 Eap, FLD3 (mutation in domain 3 of full-
length), FLD4 (mutation in domain 4 of full-length), 3L4D3 (mutation in domain 3 of two 
domain Eap 3L4), 3L4D4 (mutation in domain 4 of two domain Eap 3L4), D3 (single domain 3 
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mutant) and D4 (single domain 4 mutant) were created from their respective wild-type (WT) 
variants in the expression vector pT7HMT by site directed mutagenesis, and the corresponding 
proteins were expressed in E. coli BL21(DE3). 
 
10.2 Study on the effect of Mu50 Eap and its derivatives on human keratinocytes 
The entry of the pathogen into the host cell is initiated by bacterial binding to the host cell 
surfaces, which is thought to trigger or activate signals in the host cell that mediate the bacterial 
entry (Finlay and Falkow, 1997). A variety of molecules and macromolecular structures, 
collectively known as adhesins, mediate adherence of bacteria to cell surfaces. A wide range of 
mammalian cell surface compounds, including proteins, glycolipids, and carbohydrates, can serve 
as receptors for bacterial adhesions (Kenny et al., 1997). Like other pathogenic bacteria, S. aureus 
has developed various mechanisms allowing it to adhere to host components. It possesses a 
number of specific surface proteins which help the bacterium to attach to host factors such as 
plasma proteins (fibrinogens, fibronectins, collagen, vitronectin and thrombospondin) as well as 
to other host cell components.  
 
10.2.1 Effect of Eap on adherence of bacteria 
It has been shown that Eap act as an adhesion factor for S. aureus allowing it to attach to various 
cell types such as fibroblasts and epithelial cells (Flock et al., 2001; Hussian et al., 2002; 
Kreikemeyer et al., 2002). In this study, the effect of different Mu50 wild-type and mutant 
proteins on adherence of S. aureus to eukaryotic cells was studied. In particular, we were very 
interested to determine whether the change of the putative phosphorylation sites in domains 3 and 
4 - the tyrosine residues in the conserved YXNX motifs of Eap - might affect bacterial adherence 
to keratinocytes. We found that preincubation of keratinocytes with the full-length wild-type 
Mu50 Eap (FLWT) and the unmutated domain 3 and 4 fragment, 3L4WT, increased the 
adherence of S. aureus to keratinocytes, and this adhesion phenotype was reduced with the 
mutated versions of these derivatives  (FLD3, FLD4, 3L4D3 and 3L4D4) (Figure 22). However, 
the preincubation of HaCaT cells with single domains Eap (D3WT and D4WT) and their mutated 
counterparts (D3M and D4M) did not increase the adhesion of S. aureus to the eukaryotic cells, 
suggesting the need of at least two Eap repeats for this type of host cell interaction. Likewise, the 
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addition of full-length Eap of S.aureus Newman was able to enhance the adherence of S. aureus 
to fibroblast but the single domain fragments (D1 to D5) were not able to show this effect 
(Hussian et al., 2008), which correlates well with our findings.  
 
10.2.2 Effect of Eap on internalization of bacteria 
The evasion of the host immune system by internalization into host cells is a strategy used by a 
number of Gram-positive bacteria including S. aureus, Listeria monocytogenes, Streptococcus 
pyogenes and Enterococus faecalis (Ireton et al., 1996; Isberg et al., 1990; Wells et al., 2000). In 
addition, S. aureus can invade a variety of nonprofessional phagocyte cell types including 
cultured endothelial cells (Vercellotti et al., 1984; Ogawa et al., 1985), epithelial cells 
(Dziewanowska et al., 1999), fibroblasts and kidney cells (Sinha et al., 1999). Moreover, it was 
shown that the S. aureus FnBPs play a crucial role in the internalization process by promoting an 
actin-mediated phagocytosis of the adherent bacteria (Dziewanowska et al., 1999; Peacock et al., 
1999; Sinha et al., 1999). However, bacteria lacking FNBPs can still internalize, although at a 
lower rate, and it was suggested that Eap might contribute to this process (Hagger et al., 2003). 
 
Following our adhesion findings, we observed that the preincubation of keratinocytes with the 
Mu50 full-length Eap significantly enhanced the internalization of SA113 into keratinocytes. 
Interestingly, this effect appeared to be reduced when the mutated full-length variants FLD3 and 
FLD4 were used, with FLD4 showing a significantly decreased internalization if compared to the 
wild-type (Figure. 23 A). Similarly, preincubation of HaCaT with the mutated two-domain Eap 
fragments 3L4D3 and 3L4D4 yielded a decreased internalization of bacteria than the 
preincubated with the 3L4 wild-type fragment, with the differences between 3L4FL and 3L4D4 
being again significant Figure. 23 B. Neither of the single domain Eap fragments (D3WT, D3M, 
D4WT and D4M) (Figure. 23 C) affected the internalization rate of S. aureus, suggesting that at 
least two domains of this protein need to be present to exert such an effect. The latter findings are 
in line with a recent study on Eap from strain Newman (Hussian et al., 2008), in which the 
authors observed an enhanced invasion of S. aureus into fibroblast in presence of the full-length 
protein and an Eap fragment consisting of the domains 1 to 3, while the co-cultivation of S. 
aureus and fibroblasts with all single domains (D1 to D5) did not affect the invasiveness. Our 
findings presented here now suggest that the tyrosine residues of the YXNX motifs might be 
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involved in this internalization process. Interestingly, in our study, the decrease in internalization 
was observed with both full-length mutants P< 0.01, (the FLD3 mutant having the mutation in 
the YXNX motif of domain 3, and the FLD4 mutant having the mutation in the YXNX motif of 
domain 4) compared to the wild-type suggesting both motifs to be involved in this phenomenon. 
Thus, it is tempting to speculate that the inactivation of both tyrosine residues (domain 3 and 
domain 4) in the Mu50 Eap would lead to an even larger reduction in the internalization, a 
hypothesis that was tried to be addressed by the construction of the respective double mutant, 
FLD3-D4, which, however, was not obtained in the time frame of this thesis.  
 
10.2.3 Effect of Eap on proliferation of HaCaT cells 
The effect of Eap on the proliferation of eukaryotic cells has been addressed by several studies 
(Sobke et al., 2006; Hussain et al., 2008; Wang et al., 2010). Eap was shown to inhibit the T-cell 
proliferation, the DTH (Delayed-Type Hypersensitivity) response, and to induce T-cell death by 
apoptosis (Lee et al., 2002). In this work, we studied the effect of Mu50 Eap and its variants on 
the proliferation of keratinocytes. Here, we observed that the proliferation of keratinocytes was 
affected by the Mu50 Eap in a dose-dependent manner (Figure 25). Interestingly, our findings 
correlated well with the results obtained on proliferation of PBMC in the presence of Newman 
Eap where the higher concentrations inhibited this process (Hussain et al., 2008).  
 
By analyzing the effects of the Mu50 Eap derivatives on the proliferation of HaCaT keratinocytes 
(Figure 26), we found that the mutated variants had a similar effect on the proliferation of 
keratinocytes as their respective wild-type versions. However, the single domains were less 
efficient in suppressing the KGF-induced proliferation than the two-domain and full-length 
variants. These findings suggest that the tyrosines of the YXNX motifs are not likely to be 
involved in the Eap effect on cell proliferation. However, as we have only mutants in one of the 
YXNX motifs, we cannot exclude that the remaining tyrosines present in the other two domains 
might be sufficient to induce the inhibitory effect of Eap on cell proliferation. Nevertheless, it 
appears that at least two domain repeats of the protein are needed to exert this effect on HaCaT 
cells; this finding contrasts with the results reported by Hussain et al. (2008) who demonstrated 
that the treatment of PBMCs with Eap monomers results in a decreased proliferation rate of this 
cell type. 
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10.2.4 Effect of Eap on KGF induced ERK phosphorylation 
Eap is known to inhibit the Ras-dependent signaling pathway by interfering with the Ras-GTP 
formation (Sobke et al., 2006). Thus, in this work, we were interested see the effect of Mu50 Eap 
and its derivatives on the KGF-induced ERK 1/2 phosphorylation in HaCaT cells. Similar to the 
proliferation assay, we found that the full-length Eap protein and its mutated derivatives (FLWT, 
FLD3, FLD4), as well as all the two domain Eap fragments (3L4WT, 3L4D3 and 3L4D4), were 
able to repress the KGF-induced phosphorylation of ERK 1/2. The single domain Eap fragments 
(D3WT, D4WT, D3M, and D4M) did not interfere with the KGF-induced ERK 1/2 
phosphorylation, suggesting once again that at least a repeat of two Eap domains is needed for 
activity (Figures 24). Additionally, it became clear that the modifications of the tyrosine (Y) in 
the YXNX motifs of domains 3 and 4 did not alter the Eap effect on ERK phosphorylation, 
indicating that the putative phosphorylation of these motifs might not be required for this type of 
Eap activity. However, we cannot exclude the fact that the exchange of tyrosine to phenylalanine 
in one of the YXNX motif present in Eap was not sufficient to suppress the effect of Eap on ERK 
signaling indicating once again the need of YXNX double or triple mutants to answer this 
question. 
 
10.3 Potential role of the YXNX motif in Eap 
Protein phosphorylation at tyrosine residues is nowadays considered a fundamental process in the 
pathogenesis of a number of microorganisms (Cozzane et al., 2004; Manai et al., 1983). Several 
bacterial pathogens have been shown to use secretion systems to inject tyrosine kinase substrates 
into host cells to manipulate the host cell functions (Selbach et al., 2009). The Helicobacter 
pylori protein CagA, for instance, is translocated into gastric epithelial cells, where it is 
phosphorylated by Src- and Abl-tyrosine kinases (Poppe et al., 2007; Selbach et al., 2002; Stein 
et al., 2002; Tammer et al., 2007). Once phosphorylated, CagA binds to Src homology SH2-
containing proteins, thereby activating multiple pathways which stimulate among others actin 
polymerization and pedestal formation (Covacci and Rappuoli, 2000). 
 
Based on our findings presented in this study, we hypothesize that the S. aureus Eap can be 
phosphorylated, and that this affects the activity of the secreted protein, especially during the 
process of adhesion and internalization. Support for this assumption is given by preliminary 
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findings made by S. Bur (unpublished data), showing that the treatment of the full-length Eap 
(FLWT) with acetylphosphate reduces the internalization rate of S. aureus into keratinocytes. 
Other preliminary data indicate on the other hand that this exoprotein is secreted by the bacterium 
in an unphosphylated state, as Western blot analyses with an antibody specific to phosphor-
tyrosines did not react with Eap (V. Molle, unpublished data). Taking into account that the 
secreted Eap can rebind to the bacterial cell surface via the cell wall-anchored neutral 
phosphatase, one can assume that it might be of interest for the bacterium to excrete Eap in an 
unphosphorylated state in order to exerts its full activity. Once bound to the eukaryotic cell, Eap 
might become phosphorylated at its YXNX motifs by kinases provided by the host cell, which in 
turn enhances the adhesion/internalization process. Whether this phosphorylation is mediated by 
eukaryotic cell kinases present on the cell surface or takes place within the cytosol of the 
eukaryotic cell, still needs to be identified. Here, both possibilities are feasible, since the 
extracellular Eap is effectively bound the cell membrane of keratinocytes, taken up by the 
eukaryotic cell and released into the cytosol (I. Joost and S. Bur, unpublished data).  
 
In analogy to CagA of H. pylori and considering the above mentioned unpublished data of our 
laboratory, it is feasible that the phosphorylation of Mu50 Eap (Eap-P) at tyrosine residues in 
YXNX motifs might promote binding of Eap-P to Src homology (SH2) containing proteins such 
as GRB2, thereby increasing actin polymerization, which in turn enhances the bacterial uptake 
(the hypothetical functions of Eap on internalization and cell signaling are illustrated in Figure 
27). Other functions of Eap, like the interference with the KGF-stimulated ERK phosporylation 
or the regulatory circuits that are effective during proliferation either do not require the 
phosphorylation of the tyrosines of the YXNX motifs of Eap, or the phosphorylation of some but 
not all the YXNX motifs present in this protein are sufficient to be effective in the underlying 
eukaryotic cell signaling pathways. Experiments are ongoing in order to address these questions. 
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Figure 27: Cellular functions of Eap. Eap might interact with Clathrin to modulate the 
intracellular trafficking of vesicles, or it is bound by and translocated into the eukaryotic cell by 
yet unidentified ligands/mechanisms, where it is (in part) tyrosine phosphorylated by a eukaryotic 
cell kinase. Phosphorylated Eap (Eap-P) might bind to Src homology (SH)2-containing proteins 
present in the cytoplasm to activate the Arp2/3 (a seven subunit protein play a role in actin 
cytoskeleton) pathway which enhances actin polymerization and subsequently increases the 
internalization of bacteria. Additionally, Eap (and Eap-P) interferes with the MAP signaling 
cascade to alter the transcription of nuclear genes. In the figure, Emp - Extracellular matrix 
binding protein; Ebh – Extracellular matrix binding protein homologue. 
 
Consequently, the scientific interest in bacterial pathogenesis has been growing in recent years 
because of the increasing bacterial resistance to antibiotics and the emergence of new microbial 
diseases. Tyrosine phosphorylation in bacteria represents an important regulatory device of 
bacterial physiology.  As a result, it is essential to improve our understanding of the molecular 
and cellular mechanisms of bacterial pathogenesis in order to allow a better understanding of this 
process. In this context, the study of the conserved YXNX motifs in the Mu50 Eap and the 
phosphorylation on conserved tyrosine residues in this domain might involve a new concept for 
cell signaling and pathogenesis and sets the foundation for a novel approach of the problem. 
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12 Appendix 
 
APPENDIX I . 1 
 
 
Schematic diagram of molecular cloning of Mu50 Eap domain-insert in pT7HMT vector 
starting from expression vector pET28 (picture derived after Geisbrecht et al, 2006). The 
expression plasmid pET28 (A) was digested with NdeI and XhoI, and an insert (c-myc and TEV) 
digested with same restriction enzyme was ligated (B) to form a construct having pET28 with c-
myc and TEV (C). The vector was designed with SalI and XhoI, and an insert of polycloning site 
digested with same restriction enzymes was ligated (D) to form a expression construct pT7HMT 
(E). The expression construct of Mu50 Eap full length (FL) and its various domains were 
prepared in pT7HMT. For this, the vector was digested with SalI and NotI, and an insert of Eap 
FL (and tandem repeats) digested with same restriction enzymes were cloned (G). 
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APPENDIX I . 2 
 
Sequencing results of mutated plasmid of Mu50 Eap and its repeats 
1. FLD3 
 
 
 
 
2. FLD4 
 
 
 
 
3. 2L4D3 
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4. 2L4D4 
 
 
5. 3L4D3 
 
 
 
 
6. 3L4D4 
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7. D3 mutant 
 
 
 
8. D4 mutant 
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APPENDIX I . 3  
 
 94 
 
The Clustal W2 alignment of the amino acids sequences of Eap from fourteen different 
strains of Staphylococcus aureus species. The aminoacid sequences were retrieved from EMBL 
data base (http://www.ebi.ac.uk/embl/) and alignment was performed by the Clustal W. The 14 
different strains of S. aureus Eap includes Mu50 (SAV1938), RF122 (SAB1873c), N315 
(SA1751), JH9 (A5IUA7), CI-7 (AJ243790), USA300 (ABX29943), MSSA476 (SAS1861), 
MW2 (EFK80959.1) , 8325 (ABD31208), COL (AAW36971), FDA547 (Q53599), Newman 
mapN (AJ132841), MRSA252 (SAR2030) and Wood46 map-W (AJ245439).  
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APPENDIX I . 4 
 
Agarose gel electrophoresis of the insert of Mu50 Eap. The amplification of positive clones 
using PCR during the mutagenesis is shown.  A. Amplification of Mu50 full length (FL) Eap 
and its mutants: lane 1- marker, lane 2- FLWT, lane 3 - FLD3, lane 4 - FLWT, lane 5 - FLD4; 
B. Amplification of Mu50 three domain Eap  (2L4):  lane 1- marker, lane 2 - 2L4D3, lane 3 - 
2L4D4; C. Amplification of Mu50 two domain Eap  (3L4): lane 1- marker, lane 3 - 3L4WT, 
lane 4 - 3L4D3, lane 5 - 3L4D4; D. Amplification of Mu50 single domain Eap: lane 1- marker, 
lane 2 - D3WT, lane 3 - D3M, lane 4 - D4WT, lane 5 - D4M. 
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APPENDIX II 
A. INSTRUMENTS 
Instrument Characteristics Company 
FPLC  Bio-Rad 
Electrophoresis unit Trans-blot SD, Semi-dry transfer 
cell 
Bio-Rad 
Balance  
 
Mettler PC-4400,  
Delta range 
 
Centrifuge Eppendorf, 5810R 
Eppendorf, 5417R 
Eppendorf 
Eppendorf 
Electroporator   Bio-Rad 
Gel dryer   Bio-Rad 
Culture Bench/Laminar 
flow 
 Heraeus Safe 
pH meter PHM220 lab pH meter Radiometer, Meterlab 
Power supply unit Electrophoresis power  
ECPS 301 
Amersham Bioscience 
Water Bath  GFL 
Incubator Multitron 
 
Infors-HT 
Heraeus Electronic 
Spectrophotometer Helios Gene-Quantpro 
Unicam 
Vortex VORTE Gene-2 Scientific Industries 
Plate reader Wallace Victor2 Perkin Elmer Life 
Science 
Nitrocellulose transfer 
membrane 
 Whatmann Protran® 
Room shaker/Agitator  IKA-VIBRAX-VXR 
Magnetic stirrer  IKA-COMBIMAG-
RET 
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B. CHEMICALS 
All commercially obtained materials used in this work were of the finest quality available 
purchased from the companies listed below: 
 
C. ENZYMES/MARKER 
Proteinase K, Qiagen 
Prestained Protein ladder, Fermentas life science 
Stratagene Ltd, Cambridge, UK 
New England Biolabs 
CLONTECH Laboratories  
MBI Fermentas  
Promega Corporation 
 
C. KITS 
 
Purpose  Company 
Plasmid DNA purification  Qiagen GmbH 
Quick Change Site 
directed mutagenesis kit 
 Stratagene 
Endotoxin detection  Lonza 
Protein quantification BC 
Assay Kit 
 Thermo Scientific 
Click-iT EdU Microplate  
Assay 
 
 Invitogen 
D. COLUMN MATERIALS FOR PROTIEN PURIFICATION 
Affinity column: Ni-NTA GE Healthcare  
Size exclusion chromatography: Superdex-75, GE Healthcare. 
 
E. CONSUMABLES 
Amersham Pharmacia Biotech 
Endotrap, hyglos 
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Fisher Scientific 
Tissue culture discs, Falcon, Becton Dickinson labware  
MicroTestTM 96, Falcon, Becton Dickinson labware 
24 well -, 6 well - cell culture plate, Cellstar  
Tissue culture disc 100 x 20 mm, Sarstedt 
Millipore  
 
 
APPENDIX III 
 
1. Culture media 
i. TB broth 
A 
 
Bacto tryptone 12 g 
Bacto yeast 
extract 
24 g 
Glycerin 4 ml 
Add d/w up to 900 ml and 
autoclave it 
B 
 
KH2PO4 2.31 g 
K2HPO4 12.54 g 
Add d/w up to 100 ml 
and autoclave it 
                 Mix solution A and B for use  
 
ii. Medium A 
 
Bacto Tryptone 10 g 
Yeast Extract 2.5  
5M Nacl 1.00 ml 
1M KCl 1.25 ml   
1 M MgCl2 5.00 ml   
1M MgSO4 5.00 ml   
Add d/w up to 500 ml and autoclave it 
 
iii. Medium B  
0.2 M PIPES (10 mM, pH 6.4) 12.50 ml 
1.0 M MnCl2 (55 mM) 13. 75 ml   
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1.0 M CaCl2 (15 mM) 3.75 ml     
1.0 M KCl  (250 mM) 62.50 ml 
Add d/w up to 250 ml and autoclave it 
  
iv. SOC Medium  
Trypton 2% 
Yeast extract 0.5%  
NaCl 10 mM  
KCl 2.5 mM  
MgCl2 10 mM  
Adjust pH 7.0, autoclave, add 20 mM glucose and filter sterilize by 0.22-micron filter. 
 
2. ANTIBIOTICS AND OTHERS 
                                          
Antibiotics Stock solution Solvent Working conc. 
Kanamycin 50 mg/ml water 50 µg/ml 
 
 
3. BUFFERS AND COMMONLY USED SOLUTIONS 
i. Common Buffers 
a. 10 X TSB  
Tris 30 g 
NaCl 80 g 
KCl 2 g 
pH 7.4, HCl,  add d/w up to 1000 ml 
b. 10 X PBS  
NaCl 81.8 g 
KCl 2 g 
Na2HPO4.2H2O 16 g 
KH2PO4 2 g 
pH 7.4, HCl,  add d/w up to 1000 ml 
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c. Potassium phosphate buffer (10 mM, pH 7.4) 
1M K2HPO4 8.4 ml 
1M KH2PO4 1.6 ml add d/w up to 1000 ml 
 
ii. BUFFERS AND SOLUTIONS FOR AGAROSE GEL ELECTROPHORESIS 
10 x TAE Buffer 
 
Tris base 242.28 g  
EDTA-Na 18.61 g 
Acetic acid 60.05 ml 
 pH 8.5 ± 0.2 Add  
d/w up to 1000 ml 
10 x Loading buffer 
Bromophenol 
blue 
2.5 mg 
Xylencyanole 2.5 mg 
Glycerol 300 µl 
add d/w up to 1 ml 
iii. Buffers and solutions for protein purification 
 
A. Denaturing cell lysis buffer  
0.1 M Tris, pH 8.0 
6 M Guanidine-HCl 
 
B. Buffer for affinity chromatography 
i. Denaturing wash buffer   
20 mM Sodium phosphate buffer, pH 6.0 
500 mM NaCl 
10 mM imidazole 
8 M Urea,  
add d/w up to 500 ml 
ii. Denaturing elution buffer  
20 mM Sodium phosphate buffer, pH 6.0 
500 mM NaCl 
200 mM imidazole 
8 M Urea 
add d/w up to 200 ml 
 
 101 
iii. Native buffer   
20 mM Tris buffer, pH 8.0 
500 mM NaCl 
add d/w up to 500 ml 
iv. Native wash buffer  
20 mM Tris buffer, pH 8.0 
500 mM NaCl 
10 mM imidazole 
add d/w up to 500 ml 
v. Native elution buffer  
20 mM Tris buffer, pH 8.0 
500 mM NaCl 
500 mM imidazole 
add d/w up to 200 ml 
 
iv. Buffer for size exclusion chromatography (Buffer D) 
Potassium phosphate buffer (10 mM, pH 7.4). 
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APPENDIX IV 
 
1. Buffers and solutions for polyacrylamide gel electrophoresis 
 
separating gel 
 
Final acrylamide concentration Stock solutions 
10% 12% 15% 
4 x LT   3.75 ml 3.75 ml 3.75 ml 
10% APS  75 µl 75 µl 75 µl 
dest.H2O ad 15 ml ad 15 ml ad 15 ml 
30% AA/Bis  5.0 ml 6.0 ml 7.5 ml 
TEMED 7.5 µl 7.5 µl 10 µl 
 
 
stacking gel Stock solutions 5% acrylamide concentration 
4 x UT 
2.5 ml 
10% APS 50 µl 
Dest.H2O ad 10 ml 
30% AA/Bis 1.6 ml 
TEMED 5 µl 
 
 
4 x Buffer for 
separating gel (LT) 
 
1.5 M Tris/Cl, pH 8.8 
0.4% SDS 
 
4 x Buffer for 
stacking gel (UT) 
 
0.5 M Tris/Cl, pH 6.8 
0.4% SDS 
 
2 x SDS loading 
buffer  
 
125 mM Tris/Cl, pH 6.8 
20% Glycerol 
4% SDS 
 10% β-mercaptoethanol 
0.004% Bromphenol blue 
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Staining solution  0.1% Coomassie Brilliant Blue G-250  
40% Methanol 
10% Acetic acid 
 
Destaining 
solution  
 
25% Methanol 
10% Acetic acid 
 
APPENDIX V 
Radio-Immunoprecipitation assay (RIPA) buffer 
 50 mM Tris-HCl, pH 7.4,  
1% w/v Igepal™,  
0.25% w/v desoxycholate,  
150 mM NaCl,  
1 mM EGTA,  
1 mM NaF, 
0.5 mM sodium orthovanadate, 
1 mM sodium pyrophosphate, 
2 µg/ml aprotinin,  
5 µg/ml leupeptin, 
10 µg/ml pepstatin A, 
 0.2 mg/ml PMSF 
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